サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
市場調査レポート
商品コード
1389673

マラリア・鎌状赤血球症治療薬の世界市場：規模・予測、世界・地域別シェア、動向、成長機会分析、調査範囲：治療薬別、投与経路別、流通チャネル別

Malaria and Sickle Cell Disease Treatment Market Size and Forecasts, Global and Regional Share, Trends, and Growth Opportunity Analysis Report Coverage: By Treatment, Route of Administration, and Distribution Channel
出版日: | 発行: The Insight Partners | ページ情報: 英文 420 Pages | 納期: 即納可能 即納可能とは

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=156.76円
マラリア・鎌状赤血球症治療薬の世界市場：規模・予測、世界・地域別シェア、動向、成長機会分析、調査範囲：治療薬別、投与経路別、流通チャネル別
出版日: 2023年11月03日
発行: The Insight Partners
ページ情報: 英文 420 Pages
納期: 即納可能 即納可能とは
  • 全表示
  • 概要
  • 図表
  • 目次
概要

マラリア・鎌状赤血球症治療薬市場は、2022年の44億5,700万米ドルから2030年には291億7,900万米ドルに成長すると予測され、2022年から2030年までのCAGRは26.5%と推定されます。マラリア・鎌状赤血球症治療薬市場は、マラリアや鎌状赤血球症の有病率の増加や、マラリア・鎌状赤血球症に対する認識を高めるための政府イニシアチブの高まりにより成長しています。しかし、抗マラリア薬の偽造やその後の薬剤耐性といった要因が市場の成長を抑制しています。

抗菌薬耐性は、マラリアのような多くの病気のリスクに一般市民をさらす可能性があります。この課題を克服するためには、新薬の研究開発が最良の戦略と考えられており、その結果、抗マラリア薬やSCD治療薬／ワクチンのパイプラインはますます強固なものになってきています。官民パートナーシップは、マラリアと鎌状赤血球症の治療に関する調査活動を加速させています。例えば、非営利団体であるMedicines for Malaria Venture (MMV) は、多くの製薬会社と協力し、新しい治療法を開発することでマラリアの負担を軽減しています。

臨床開発中の抗マラリア薬や鎌状赤血球症治療薬/ワクチンの一覧は、下記のとおりです (一部)：

表1：臨床開発中のマラリア治療薬／ワクチン／化合物

薬剤名開発企業臨床試験の段階
アルテフェノメルSanofiフェーズIIb
KAE609Novartis AGフェーズIIb
KAF156Novartis AGフェーズIIb
DSM265Takeda Pharmaceutical CompanyフェーズIIa
SANARIA PfSPZ-GA1SanariaフェーズII
SANARIA PfSPZ Vaccine - Radiation Attenuated PfSPZ VaccineSanariaフェーズII
SANARIA PfSPZ-CVacSanariaフェーズII
MSP3-CRM-Vac4AllVac4AllフェーズI
肝特異抗原3 (LSA3)Vac4AllフェーズIIa

Source: Company Website, The Insight Partners Analysis.

表2：臨床開発中の鎌状赤血球症治療薬／ワクチン／化合物

薬剤名開発企業臨床試験の段階
InclacumabPfizerフェーズIII
VoxelotorPfizerフェーズIII
GBT021601PfizerフェーズII
PF-07209326PfizerフェーズII
RG6107RocheフェーズII
GSK4172239DGSKフェーズI
BEAM¬-101Beam TherapeuticsフェーズI/II
HGB-206Bluebird Bio, Inc.フェーズI/II
HGB-210Bluebird Bio, Inc.フェーズIII
ALXN1820AlexionフェーズII
NCT05714969Takeda Pharmaceutical Company Limitedフェーズ2b
NCT03997760Takeda Pharmaceutical Company LimitedフェーズI

Source: Company Website, The Insight Partners Analysis.

そのため、臨床開発中の抗マラリア薬やSCD治療薬/ワクチンの数が増加しており、今後の市場成長を後押しすると予想されます。

本レポートでは、マラリア・鎌状赤血球症治療薬市場を以下のように区分しています：

マラリア・鎌状赤血球症 (SCD) 治療薬市場は、治療薬、投与経路、流通チャネル、地域に基づいて区分されます。治療薬に基づき、市場はマラリアと鎌状赤血球症に分けられます。投与経路では、マラリア・鎌状赤血球症 (SCD) 治療薬市場は経口剤と非経口剤に分けられます。流通チャネルでは、直接販売、病院薬局、小売薬局、オンライン薬局、その他に分類されます。地域別では、マラリア・鎌状赤血球症治療薬市場は北米 (米国、カナダ、メキシコ)、欧州 (英国、ドイツ、フランス、イタリア、スペイン、その他欧州)、アジア太平洋 (中国、日本、インド、オーストラリア、韓国、その他アジア太平洋)、中東・アフリカ (サウジアラビア、UAE、南アフリカ、ケニア、タンザニア、ルワンダ、ナイジェリア、ガーナ、ウガンダ、アンゴラ、カメルーン、セネガル、ザンビア、その他中東・アフリカ)、中南米 (ブラジル、アルゼンチン、その他中米) に分類されます。

投与経路に基づく洞察

投与経路別に見ると、マラリア治療薬市場は経口剤と非経口剤に二分されます。2022年の市場シェアは経口剤が上回り、2020～2030年のCAGRは非経口剤が上回ると推定されます。経口ドラッグデリバリーは、高い患者コンプライアンス、非侵襲性、最小限の無菌制約、費用対効果、剤形設計の柔軟性、製造プロセスの容易さなどを提供するため、薬剤投与の最も理想的で適切な経路です。投与の容易さや長期的なコスト効率といった利点が、経口薬の採用を後押しする主な要因となっています。

流通チャネルに基づく洞察

流通チャネルに基づき、マラリア・鎌状赤血球症 (SCD) 治療薬市場は、直接入札、病院薬局、小売薬局、オンライン薬局、その他に区分されます。直接入札セグメントが2022年に最大の市場シェアを占めました。入札とは、一定の金額で特定の業務や物品を提供することを申し出ることです。入札手続きの最初のステップでは、請負業者は工事のための封印入札を提出するか、特定の期限内に特に計画されたサービスや製品を提供するよう求められます。インドの電子入札手続きは、政府または特定のクライアントのための業務がタイムリーに完了するように設計されています。

マラリア・鎌状赤血球症治療薬市場に関する報告書を作成する際に参照した主な一次情報および二次情報には、世界保健機関 (WHO)、米国国勢調査局、CDCなどがあります。

目次

第1章 イントロダクション

第2章 エグゼクティブサマリー

第3章 調査手法

第4章 マラリア・鎌状赤血球症治療薬：市場情勢

  • PEST分析：マラリア治療薬
  • PEST分析：鎌状赤血球症治療薬

第5章 マラリア・鎌状赤血球症治療薬市場：主な産業力学

  • 主な市場促進要因
    • マラリアと鎌状赤血球症の有病率の増加
    • マラリアと鎌状赤血球症に関する意識向上への取り組みの高まり
  • 市場抑制要因
    • 鎌状赤血球症治療の選択肢の欠如、偽造抗マラリア薬の入手可能性、その後の薬剤耐性
  • 市場機会
    • 各企業による戦略的イニシアチブの高まり
  • 今後の動向
    • 新薬とワクチンのパイプラインの拡大
  • 影響分析

第6章 マラリア・鎌状赤血球症治療薬市場：世界市場分析

  • マラリア治療薬市場の収益 (2022年～2030年)
  • 鎌状赤血球症治療薬市場の収益 (2022年～2030年)
  • 地域別の市場収益の分析 (2022年～2030年)
  • マラリアの疫学データ
    • マラリアの感染特性、免疫、臨床的特徴
    • マラリア推定患者数と推定死亡数
      • マラリア関連の研究開発資金 (2021年)
      • マラリア制圧のための資金 (2021年)
  • 資金配分メカニズム
    • 国際的基金
      • USAIDブルンジ・マラリア事業計画2022年度
      • マラリア治療薬の調達シナリオ
  • マラリアの償還シナリオ
  • 鎌状赤血球症
      • 鎌状赤血球症 (SCD) の疫学データ (2020年)
  • 鎌状赤血球症 (SCD) の資金調達
  • 鎌状赤血球症の償還シナリオ
  • 医療施設数と医療費

第7章 マラリア・鎌状赤血球症治療薬の市場：収益と予測、治療薬別 (2030年まで)

  • マラリア治療薬市場：収益シェア、治療薬別 (%、2022年・2030年)
  • 鎌状赤血球症治療薬市場：収益シェア、治療薬別 (%、2022年・2030年)
  • マラリア
  • 鎌状赤血球症 (SCD)

第8章 マラリア・鎌状赤血球症治療薬の市場：収益と予測、投与経路別 (2030年まで)

  • マラリア治療薬市場：収益シェア、投与経路別 (%、2022年・2030年)
  • 鎌状赤血球症治療薬市場：収益シェア、投与経路別 (%、2022年・2030年)
  • 経口
  • 非経口

第9章 マラリア・鎌状赤血球症治療薬の市場：収益と予測、流通経路別 (2030年まで)

  • マラリア治療薬市場：収益シェア、流通経路別 (%、2022年・2030年)
  • 鎌状赤血球症治療薬市場：収益シェア、流通経路別 (%、2022年・2030年)
  • 直接入札
  • 病院薬局
  • 小売薬局
  • オンライン薬局
  • その他

第10章 マラリア・鎌状赤血球症治療薬の市場：地域別分析

  • 北米
    • 米国
    • カナダ
    • メキシコ
  • 欧州
    • フランス
    • 英国
    • イタリア
    • ドイツ
    • スペイン
    • その他欧州
  • アジア太平洋
    • 中国
    • 日本
    • インド
    • 韓国
    • オーストラリア
    • その他アジア太平洋
  • 中東・アフリカ
    • サウジアラビア
    • アラブ首長国連邦 (UAE)
    • 南アフリカ
    • ケニア
    • タンザニア
    • ルワンダ
    • ナイジェリア
    • ガーナ
    • ウガンダ
    • アンゴラ
    • カメルーン
    • セネガル
    • ザンビア
    • その他中東・アフリカ
  • 中南米
    • ブラジル
    • アルゼンチン
    • その他中南米

第11章 マラリア・鎌状赤血球症治療薬の市場：業界情勢

  • マラリア・鎌状赤血球症治療薬市場の成長戦略
    • 無機的成長戦略
    • 有機的成長戦略

第12章 企業プロファイル

  • Cipla Ltd
  • Key Facts
  • Business Description
  • Products and Services
  • Financial Overview
  • SWOT Analysis
  • Key Developments
  • Sun Pharmaceutical Industries Ltd
  • Sanofi SA
  • GSK Plc
  • Novartis AG
  • Pfizer Inc
  • Emmaus Life Sciences Inc
  • AdvaCare Pharma USA LLC
  • VLP Therapeutics LLC
  • Lupin Ltd Teva Pharmaceutical Industries Ltd

第13章 付録

第14章 付録

図表

List Of Tables

  • Table 1. Malaria and Sickle Cell Disease Treatment Market Segmentation
  • Table 2. Malaria Drugs/Vaccine/Compounds Under Clinical Development
  • Table 3. Sickle Cell Disease Drugs/Vaccine/Compounds Under Clinical Development
  • Table 4. Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn) - Treatment
  • Table 5. Sickle Cell Disease Treatment Market Revenue and Forecast to 2030 (US$ Mn) - Treatment
  • Table 6. Malaria Treatment Market Revenue and Forecast To 2030 (US$ Mn) - Hospital Pharmacies
  • Table 7. Sickle Cell Disease Treatment Market Revenue and Forecast To 2030 (US$ Mn) - Hospital Pharmacies
  • Table 8. Malaria Treatment Market Revenue and Forecast To 2030 (US$ Mn) - Retail Pharmacies
  • Table 9. Sickle Cell Disease Treatment Market Revenue and Forecast To 2030 (US$ Mn) - Retail Pharmacies
  • Table 10. North America: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn) - Treatment
  • Table 11. North America: Sickle Cell Disease Treatment Market Revenue and Forecast to 2030 (US$ Mn) - Treatment
  • Table 12. North America: Malaria Treatment Market Revenue and Forecast To 2030 (US$ Mn) - Route of Administration
  • Table 13. North America: Sickle Cell Disease Treatment Market Revenue and Forecast To 2030 (US$ Mn) - Route of Administration
  • Table 14. North America: Malaria Treatment Market Revenue and Forecast To 2030 (US$ Mn) - Distribution Channel
  • Table 15. North America: Malaria Treatment Market Revenue and Forecast To 2030 (US$ Mn) - Hospital Pharmacies
  • Table 16. North America: Malaria Treatment Market Revenue and Forecast To 2030 (US$ Mn) - Hospital Pharmacies
  • Table 17. North America: Malaria Treatment Market Revenue and Forecast To 2030 (US$ Mn) - Distribution Channel
  • Table 18. North America: Malaria Treatment Market Revenue and Forecast To 2030 (US$ Mn) - Hospital Pharmacies
  • Table 19. North America: Malaria Treatment Market Revenue and Forecast To 2030 (US$ Mn) - Retail Pharmacies
  • Table 20. US: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn) - Treatment
  • Table 21. US: Sickle Cell Disease Treatment Market Revenue and Forecast to 2030 (US$ Mn) - Treatment
  • Table 22. US: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn) - Route of Administration
  • Table 23. US: Sickle Cell Disease Treatment Market Revenue and Forecast to 2030 (US$ Mn) - Route of Administration
  • Table 24. US: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn) - Distribution Channel
  • Table 25. US: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn) - Hospital Pharmacies
  • Table 26. US: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn) - Retail Pharmacies
  • Table 27. US: Sickle Cell Disease Treatment Market Revenue and Forecast to 2030 (US$ Mn) - Distribution Channel
  • Table 28. US: Sickle Cell Disease Treatment Market Revenue and Forecast to 2030 (US$ Mn) - Hospital Pharmacies
  • Table 29. US: Sickle Cell Disease Treatment Market Revenue and Forecast to 2030 (US$ Mn) - Distribution Channel
  • Table 30. Canada: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn) - Treatment
  • Table 31. Canada: Sickle Cell Disease Treatment Market Revenue and Forecast to 2030 (US$ Mn) - Treatment
  • Table 32. Canada: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn) - Route of Administration
  • Table 33. Canada: Sickle Cell Disease Treatment Market Revenue and Forecast to 2030 (US$ Mn) - Route of Administration
  • Table 34. Canada: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn) - Distribution Channel
  • Table 35. Canada: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn) - Hospital Pharmacies
  • Table 36. Canada: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn) - Retail Pharmacies
  • Table 37. Canada: Sickle Cell Disease Treatment Market Revenue and Forecast to 2030 (US$ Mn) - Distribution Channel
  • Table 38. Canada: Sickle Cell Disease Treatment Market Revenue and Forecast to 2030 (US$ Mn) - Hospital Pharmacies
  • Table 39. Canada: Sickle Cell Disease Treatment Market Revenue and Forecast to 2030 (US$ Mn) - Distribution Channel
  • Table 40. Mexico: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn) - Treatment
  • Table 41. Mexico: Sickle Cell Disease Treatment Market Revenue and Forecast to 2030 (US$ Mn) - Treatment
  • Table 42. Mexico: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn) - Route of Administration
  • Table 43. Mexico: Sickle Cell Disease Treatment Market Revenue and Forecast to 2030 (US$ Mn) - Route of Administration
  • Table 44. Mexico: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn) - Distribution Channel
  • Table 45. Mexico: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn) - Hospital Pharmacies
  • Table 46. Mexico: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn) - Retail Pharmacies
  • Table 47. Mexico: Sickle Cell Disease Treatment Market Revenue and Forecast to 2030 (US$ Mn) - Distribution Channel
  • Table 48. Mexico: Sickle Cell Disease Treatment Market Revenue and Forecast to 2030 (US$ Mn) - Hospital Pharmacies
  • Table 49. Mexico: Sickle Cell Disease Treatment Market Revenue and Forecast to 2030 (US$ Mn) - Distribution Channel
  • Table 50. Europe: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn) - Treatment
  • Table 51. Europe: Sickle Cell Disease Treatment Market Revenue and Forecast to 2030 (US$ Mn) - Treatment
  • Table 52. Europe: Malaria Treatment Market Revenue and Forecast To 2030 (US$ Mn) - Route of Administration
  • Table 53. Europe: Sickle Cell Disease Treatment Market Revenue and Forecast To 2030 (US$ Mn) - Route of Administration
  • Table 54. Europe: Malaria Treatment Market Revenue and Forecast To 2030 (US$ Mn) - Distribution Channel
  • Table 55. Europe: Malaria Treatment Market Revenue and Forecast To 2030 (US$ Mn) - Hospital Pharmacies
  • Table 56. Europe: Malaria Treatment Market Revenue and Forecast To 2030 (US$ Mn) - Hospital Pharmacies
  • Table 57. Europe: Malaria Treatment Market Revenue and Forecast To 2030 (US$ Mn) - Distribution Channel
  • Table 58. Europe: Malaria Treatment Market Revenue and Forecast To 2030 (US$ Mn) - Hospital Pharmacies
  • Table 59. Europe: Malaria Treatment Market Revenue and Forecast To 2030 (US$ Mn) - Retail Pharmacies
  • Table 60. France: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn) - Treatment
  • Table 61. France: Sickle Cell Disease Treatment Market Revenue and Forecast to 2030 (US$ Mn) - Treatment
  • Table 62. France: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn) - Route of Administration
  • Table 63. France: Sickle Cell Disease Treatment Market Revenue and Forecast to 2030 (US$ Mn) - Route of Administration
  • Table 64. France: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn) - Distribution Channel
  • Table 65. France: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn) - Hospital Pharmacies
  • Table 66. France: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn) - Retail Pharmacies
  • Table 67. France: Sickle Cell Disease Treatment Market Revenue and Forecast to 2030 (US$ Mn) - Distribution Channel
  • Table 68. France: Sickle Cell Disease Treatment Market Revenue and Forecast to 2030 (US$ Mn) - Hospital Pharmacies
  • Table 69. France: Sickle Cell Disease Treatment Market Revenue and Forecast to 2030 (US$ Mn) - Distribution Channel
  • Table 70. UK: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn) - Treatment
  • Table 71. UK: Sickle Cell Disease Treatment Market Revenue and Forecast to 2030 (US$ Mn) - Treatment
  • Table 72. UK: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn) - Route of Administration
  • Table 73. UK: Sickle Cell Disease Treatment Market Revenue and Forecast to 2030 (US$ Mn) - Route of Administration
  • Table 74. UK: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn) - Distribution Channel
  • Table 75. UK: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn) - Hospital Pharmacies
  • Table 76. UK: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn) - Retail Pharmacies
  • Table 77. UK: Sickle Cell Disease Treatment Market Revenue and Forecast to 2030 (US$ Mn) - Distribution Channel
  • Table 78. UK: Sickle Cell Disease Treatment Market Revenue and Forecast to 2030 (US$ Mn) - Hospital Pharmacies
  • Table 79. UK: Sickle Cell Disease Treatment Market Revenue and Forecast to 2030 (US$ Mn) - Distribution Channel
  • Table 80. Italy: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn) - Treatment
  • Table 81. Italy: Sickle Cell Disease Treatment Market Revenue and Forecast to 2030 (US$ Mn) - Treatment
  • Table 82. Italy: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn) - Route of Administration
  • Table 83. Italy: Sickle Cell Disease Treatment Market Revenue and Forecast to 2030 (US$ Mn) - Route of Administration
  • Table 84. Italy: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn) - Distribution Channel
  • Table 85. Italy: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn) - Hospital Pharmacies
  • Table 86. Italy: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn) - Retail Pharmacies
  • Table 87. Italy: Sickle Cell Disease Treatment Market Revenue and Forecast to 2030 (US$ Mn) - Distribution Channel
  • Table 88. Italy: Sickle Cell Disease Treatment Market Revenue and Forecast to 2030 (US$ Mn) - Hospital Pharmacies
  • Table 89. Italy: Sickle Cell Disease Treatment Market Revenue and Forecast to 2030 (US$ Mn) - Distribution Channel
  • Table 90. Germany: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn) - Treatment
  • Table 91. Germany: Sickle Cell Disease Treatment Market Revenue and Forecast to 2030 (US$ Mn) - Treatment
  • Table 92. Germany: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn) - Route of Administration
  • Table 93. Germany: Sickle Cell Disease Treatment Market Revenue and Forecast to 2030 (US$ Mn) - Route of Administration
  • Table 94. Germany: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn) - Distribution Channel
  • Table 95. Germany: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn) - Hospital Pharmacies
  • Table 96. Germany: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn) - Retail Pharmacies
  • Table 97. Germany: Sickle Cell Disease Treatment Market Revenue and Forecast to 2030 (US$ Mn) - Distribution Channel
  • Table 98. Germany: Sickle Cell Disease Treatment Market Revenue and Forecast to 2030 (US$ Mn) - Hospital Pharmacies
  • Table 99. Germany: Sickle Cell Disease Treatment Market Revenue and Forecast to 2030 (US$ Mn) - Distribution Channel
  • Table 100. Spain: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn) - Treatment
  • Table 101. Spain: Sickle Cell Disease Treatment Market Revenue and Forecast to 2030 (US$ Mn) - Treatment
  • Table 102. Spain: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn) - Route of Administration
  • Table 103. Spain: Sickle Cell Disease Treatment Market Revenue and Forecast to 2030 (US$ Mn) - Route of Administration
  • Table 104. Spain: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn) - Distribution Channel
  • Table 105. Spain: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn) - Hospital Pharmacies
  • Table 106. Spain: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn) - Retail Pharmacies
  • Table 107. Spain: Sickle Cell Disease Treatment Market Revenue and Forecast to 2030 (US$ Mn) - Distribution Channel
  • Table 108. Spain: Sickle Cell Disease Treatment Market Revenue and Forecast to 2030 (US$ Mn) - Hospital Pharmacies
  • Table 109. Spain: Sickle Cell Disease Treatment Market Revenue and Forecast to 2030 (US$ Mn) - Distribution Channel
  • Table 110. Rest of Europe: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn) - Treatment
  • Table 111. Rest of Europe: Sickle Cell Disease Treatment Market Revenue and Forecast to 2030 (US$ Mn) - Treatment
  • Table 112. Rest of Europe: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn) - Route of Administration
  • Table 113. Rest of Europe: Sickle Cell Disease Treatment Market Revenue and Forecast to 2030 (US$ Mn) - Route of Administration
  • Table 114. Rest of Europe: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn) - Distribution Channel
  • Table 115. Rest of Europe: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn) - Hospital Pharmacies
  • Table 116. Rest of Europe: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn) - Retail Pharmacies
  • Table 117. Rest of Europe: Sickle Cell Disease Treatment Market Revenue and Forecast to 2030 (US$ Mn) - Distribution Channel
  • Table 118. Rest of Europe: Sickle Cell Disease Treatment Market Revenue and Forecast to 2030 (US$ Mn) - Hospital Pharmacies
  • Table 119. Rest of Europe: Sickle Cell Disease Treatment Market Revenue and Forecast to 2030 (US$ Mn) - Distribution Channel
  • Table 120. Asia Pacific: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn) - Treatment
  • Table 121. Asia Pacific: Sickle Cell Disease Treatment Market Revenue and Forecast to 2030 (US$ Mn) - Treatment
  • Table 122. Asia Pacific: Malaria Treatment Market Revenue and Forecast To 2030 (US$ Mn) - Route of Administration
  • Table 123. Asia Pacific: Sickle Cell Disease Treatment Market Revenue and Forecast To 2030 (US$ Mn) - Route of Administration
  • Table 124. Asia Pacific: Malaria Treatment Market Revenue and Forecast To 2030 (US$ Mn) - Distribution Channel
  • Table 125. Asia Pacific: Malaria Treatment Market Revenue and Forecast To 2030 (US$ Mn) - Hospital Pharmacies
  • Table 126. Asia Pacific: Malaria Treatment Market Revenue and Forecast To 2030 (US$ Mn) - Hospital Pharmacies
  • Table 127. Asia Pacific: Malaria Treatment Market Revenue and Forecast To 2030 (US$ Mn) - Distribution Channel
  • Table 128. Asia Pacific: Malaria Treatment Market Revenue and Forecast To 2030 (US$ Mn) - Hospital Pharmacies
  • Table 129. Asia Pacific: Malaria Treatment Market Revenue and Forecast To 2030 (US$ Mn) - Retail Pharmacies
  • Table 130. China: Sickle Cell Disease Treatment Market Revenue and Forecast to 2030 (US$ Mn) - Treatment
  • Table 131. China: Sickle Cell Disease Treatment Market Revenue and Forecast to 2030 (US$ Mn) - Route of Administration
  • Table 132. China: Sickle Cell Disease Treatment Market Revenue and Forecast to 2030 (US$ Mn) - Distribution Channel
  • Table 133. China: Sickle Cell Disease Treatment Market Revenue and Forecast to 2030 (US$ Mn) - Hospital Pharmacies
  • Table 134. China: Sickle Cell Disease Treatment Market Revenue and Forecast to 2030 (US$ Mn) - Distribution Channel
  • Table 135. Japan: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn) - Treatment
  • Table 136. Japan: Sickle Cell Disease Treatment Market Revenue and Forecast to 2030 (US$ Mn) - Treatment
  • Table 137. Japan: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn) - Route of Administration
  • Table 138. Japan: Sickle Cell Disease Treatment Market Revenue and Forecast to 2030 (US$ Mn) - Route of Administration
  • Table 139. Japan: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn) - Distribution Channel
  • Table 140. Japan: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn) - Hospital Pharmacies
  • Table 141. Japan: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn) - Retail Pharmacies
  • Table 142. Japan: Sickle Cell Disease Treatment Market Revenue and Forecast to 2030 (US$ Mn) - Distribution Channel
  • Table 143. Japan: Sickle Cell Disease Treatment Market Revenue and Forecast to 2030 (US$ Mn) - Hospital Pharmacies
  • Table 144. Japan: Sickle Cell Disease Treatment Market Revenue and Forecast to 2030 (US$ Mn) - Distribution Channel
  • Table 145. India: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn) - Treatment
  • Table 146. India: Sickle Cell Disease Treatment Market Revenue and Forecast to 2030 (US$ Mn) - Treatment
  • Table 147. India: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn) - Route of Administration
  • Table 148. India: Sickle Cell Disease Treatment Market Revenue and Forecast to 2030 (US$ Mn) - Route of Administration
  • Table 149. India: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn) - Distribution Channel
  • Table 150. India: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn) - Hospital Pharmacies
  • Table 151. India: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn) - Retail Pharmacies
  • Table 152. India: Sickle Cell Disease Treatment Market Revenue and Forecast to 2030 (US$ Mn) - Distribution Channel
  • Table 153. India: Sickle Cell Disease Treatment Market Revenue and Forecast to 2030 (US$ Mn) - Hospital Pharmacies
  • Table 154. India: Sickle Cell Disease Treatment Market Revenue and Forecast to 2030 (US$ Mn) - Distribution Channel
  • Table 155. South Korea: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn) - Treatment
  • Table 156. South Korea: Sickle Cell Disease Treatment Market Revenue and Forecast to 2030 (US$ Mn) - Treatment
  • Table 157. South Korea: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn) - Route of Administration
  • Table 158. South Korea: Sickle Cell Disease Treatment Market Revenue and Forecast to 2030 (US$ Mn) - Route of Administration
  • Table 159. South Korea: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn) - Distribution Channel
  • Table 160. South Korea: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn) - Hospital Pharmacies
  • Table 161. South Korea: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn) - Retail Pharmacies
  • Table 162. South Korea: Sickle Cell Disease Treatment Market Revenue and Forecast to 2030 (US$ Mn) - Distribution Channel
  • Table 163. South Korea: Sickle Cell Disease Treatment Market Revenue and Forecast to 2030 (US$ Mn) - Hospital Pharmacies
  • Table 164. South Korea: Sickle Cell Disease Treatment Market Revenue and Forecast to 2030 (US$ Mn) - Distribution Channel
  • Table 165. Australia: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn) - Treatment
  • Table 166. Australia: Sickle Cell Disease Treatment Market Revenue and Forecast to 2030 (US$ Mn) - Treatment
  • Table 167. Australia: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn) - Route of Administration
  • Table 168. Australia: Sickle Cell Disease Treatment Market Revenue and Forecast to 2030 (US$ Mn) - Route of Administration
  • Table 169. Australia: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn) - Distribution Channel
  • Table 170. Australia: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn) - Hospital Pharmacies
  • Table 171. Australia: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn) - Retail Pharmacies
  • Table 172. Australia: Sickle Cell Disease Treatment Market Revenue and Forecast to 2030 (US$ Mn) - Distribution Channel
  • Table 173. Australia: Sickle Cell Disease Treatment Market Revenue and Forecast to 2030 (US$ Mn) - Hospital Pharmacies
  • Table 174. Australia: Sickle Cell Disease Treatment Market Revenue and Forecast to 2030 (US$ Mn) - Distribution Channel
  • Table 175. Rest of Asia Pacific: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn) - Treatment
  • Table 176. Rest of Asia Pacific: Sickle Cell Disease Treatment Market Revenue and Forecast to 2030 (US$ Mn) - Treatment
  • Table 177. Rest of Asia Pacific: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn) - Route of Administration
  • Table 178. Rest of Asia Pacific: Sickle Cell Disease Treatment Market Revenue and Forecast to 2030 (US$ Mn) - Route of Administration
  • Table 179. Rest of Asia Pacific: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn) - Distribution Channel
  • Table 180. Rest of Asia Pacific: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn) - Hospital Pharmacies
  • Table 181. Rest of Asia Pacific: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn) - Retail Pharmacies
  • Table 182. Rest of Asia Pacific: Sickle Cell Disease Treatment Market Revenue and Forecast to 2030 (US$ Mn) - Distribution Channel
  • Table 183. Rest of Asia Pacific: Sickle Cell Disease Treatment Market Revenue and Forecast to 2030 (US$ Mn) - Hospital Pharmacies
  • Table 184. Rest of Asia Pacific: Sickle Cell Disease Treatment Market Revenue and Forecast to 2030 (US$ Mn) - Distribution Channel
  • Table 185. Middle East & Africa: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn) - Treatment
  • Table 186. Middle East & Africa: Sickle Cell Disease Treatment Market Revenue and Forecast to 2030 (US$ Mn) - Treatment
  • Table 187. Middle East & Africa: Malaria Treatment Market Revenue and Forecast To 2030 (US$ Mn) - Route of Administration
  • Table 188. Middle East & Africa: Sickle Cell Disease Treatment Market Revenue and Forecast To 2030 (US$ Mn) - Route of Administration
  • Table 189. Middle East & Africa: Malaria Treatment Market Revenue and Forecast To 2030 (US$ Mn) - Distribution Channel
  • Table 190. Middle East & Africa: Malaria Treatment Market Revenue and Forecast To 2030 (US$ Mn) - Hospital Pharmacies
  • Table 191. Middle East & Africa: Malaria Treatment Market Revenue and Forecast To 2030 (US$ Mn) - Hospital Pharmacies
  • Table 192. Middle East & Africa: Malaria Treatment Market Revenue and Forecast To 2030 (US$ Mn) - Distribution Channel
  • Table 193. Middle East & Africa: Malaria Treatment Market Revenue and Forecast To 2030 (US$ Mn) - Hospital Pharmacies
  • Table 194. Middle East & Africa: Malaria Treatment Market Revenue and Forecast To 2030 (US$ Mn) - Retail Pharmacies
  • Table 195. Saudi Arabia: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn) - Treatment
  • Table 196. Saudi Arabia: Sickle Cell Disease Treatment Market Revenue and Forecast to 2030 (US$ Mn) - Treatment
  • Table 197. Saudi Arabia: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn) - Route of Administration
  • Table 198. Saudi Arabia: Sickle Cell Disease Treatment Market Revenue and Forecast to 2030 (US$ Mn) - Route of Administration
  • Table 199. Saudi Arabia: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn) - Distribution Channel
  • Table 200. Saudi Arabia: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn) - Hospital Pharmacies
  • Table 201. Saudi Arabia: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn) - Retail Pharmacies
  • Table 202. Saudi Arabia: Sickle Cell Disease Treatment Market Revenue and Forecast to 2030 (US$ Mn) - Distribution Channel
  • Table 203. Saudi Arabia: Sickle Cell Disease Treatment Market Revenue and Forecast to 2030 (US$ Mn) - Hospital Pharmacies
  • Table 204. Saudi Arabia: Sickle Cell Disease Treatment Market Revenue and Forecast to 2030 (US$ Mn) - Distribution Channel
  • Table 205. UAE: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn) - Treatment
  • Table 206. UAE: Sickle Cell Disease Treatment Market Revenue and Forecast to 2030 (US$ Mn) - Treatment
  • Table 207. UAE: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn) - Route of Administration
  • Table 208. UAE: Sickle Cell Disease Treatment Market Revenue and Forecast to 2030 (US$ Mn) - Route of Administration
  • Table 209. UAE: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn) - Distribution Channel
  • Table 210. UAE: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn) - Hospital Pharmacies
  • Table 211. UAE: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn) - Retail Pharmacies
  • Table 212. UAE: Sickle Cell Disease Treatment Market Revenue and Forecast to 2030 (US$ Mn) - Distribution Channel
  • Table 213. UAE: Sickle Cell Disease Treatment Market Revenue and Forecast to 2030 (US$ Mn) - Hospital Pharmacies
  • Table 214. UAE: Sickle Cell Disease Treatment Market Revenue and Forecast to 2030 (US$ Mn) - Distribution Channel
  • Table 215. South Africa: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn) - Treatment
  • Table 216. South Africa: Sickle Cell Disease Treatment Market Revenue and Forecast to 2030 (US$ Mn) - Treatment
  • Table 217. South Africa: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn) - Route of Administration
  • Table 218. South Africa: Sickle Cell Disease Treatment Market Revenue and Forecast to 2030 (US$ Mn) - Route of Administration
  • Table 219. South Africa: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn) - Distribution Channel
  • Table 220. South Africa: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn) - Hospital Pharmacies
  • Table 221. South Africa: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn) - Retail Pharmacies
  • Table 222. South Africa: Sickle Cell Disease Treatment Market Revenue and Forecast to 2030 (US$ Mn) - Distribution Channel
  • Table 223. South Africa: Sickle Cell Disease Treatment Market Revenue and Forecast to 2030 (US$ Mn) - Hospital Pharmacies
  • Table 224. South Africa: Sickle Cell Disease Treatment Market Revenue and Forecast to 2030 (US$ Mn) - Distribution Channel
  • Table 225. Kenya: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn) - Treatment
  • Table 226. Kenya: Sickle Cell Disease Treatment Market Revenue and Forecast to 2030 (US$ Mn) - Treatment
  • Table 227. Kenya: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn) - Route of Administration
  • Table 228. Kenya: Sickle Cell Disease Treatment Market Revenue and Forecast to 2030 (US$ Mn) - Route of Administration
  • Table 229. Kenya: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn) - Distribution Channel
  • Table 230. Kenya: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn) - Hospital Pharmacies
  • Table 231. Kenya: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn) - Retail Pharmacies
  • Table 232. Kenya: Sickle Cell Disease Treatment Market Revenue and Forecast to 2030 (US$ Mn) - Distribution Channel
  • Table 233. Kenya: Sickle Cell Disease Treatment Market Revenue and Forecast to 2030 (US$ Mn) - Hospital Pharmacies
  • Table 234. Kenya: Sickle Cell Disease Treatment Market Revenue and Forecast to 2030 (US$ Mn) - Distribution Channel
  • Table 235. Tanzania: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn) - Treatment
  • Table 236. Tanzania: Sickle Cell Disease Treatment Market Revenue and Forecast to 2030 (US$ Mn) - Treatment
  • Table 237. Tanzania: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn) - Route of Administration
  • Table 238. Tanzania: Sickle Cell Disease Treatment Market Revenue and Forecast to 2030 (US$ Mn) - Route of Administration
  • Table 239. Tanzania: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn) - Distribution Channel
  • Table 240. Tanzania: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn) - Hospital Pharmacies
  • Table 241. Tanzania: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn) - Retail Pharmacies
  • Table 242. Tanzania: Sickle Cell Disease Treatment Market Revenue and Forecast to 2030 (US$ Mn) - Distribution Channel
  • Table 243. Tanzania: Sickle Cell Disease Treatment Market Revenue and Forecast to 2030 (US$ Mn) - Hospital Pharmacies
  • Table 244. Tanzania: Sickle Cell Disease Treatment Market Revenue and Forecast to 2030 (US$ Mn) - Distribution Channel
  • Table 245. Rwanda: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn) - Treatment
  • Table 246. Rwanda: Sickle Cell Disease Treatment Market Revenue and Forecast to 2030 (US$ Mn) - Treatment
  • Table 247. Rwanda: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn) - Route of Administration
  • Table 248. Rwanda: Sickle Cell Disease Treatment Market Revenue and Forecast to 2030 (US$ Mn) - Route of Administration
  • Table 249. Rwanda: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn) - Distribution Channel
  • Table 250. Rwanda: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn) - Hospital Pharmacies
  • Table 251. Rwanda: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn) - Retail Pharmacies
  • Table 252. Rwanda: Sickle Cell Disease Treatment Market Revenue and Forecast to 2030 (US$ Mn) - Distribution Channel
  • Table 253. Rwanda: Sickle Cell Disease Treatment Market Revenue and Forecast to 2030 (US$ Mn) - Hospital Pharmacies
  • Table 254. Rwanda: Sickle Cell Disease Treatment Market Revenue and Forecast to 2030 (US$ Mn) - Distribution Channel
  • Table 255. Nigeria Malaria Treatment Market, by Treatment - Revenue and Forecast to 2030 (USD Million)
  • Table 256. Nigeria: Sickle Cell Disease Treatment Market Revenue and Forecast to 2030 (US$ Mn) - Treatment
  • Table 257. Nigeria: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn) - Route of Administration
  • Table 258. Nigeria: Sickle Cell Disease Treatment Market Revenue and Forecast to 2030 (US$ Mn) - Route of Administration
  • Table 259. Nigeria: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn) - Distribution Channel
  • Table 260. Nigeria: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn) - Hospital Pharmacies
  • Table 261. Nigeria: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn) - Retail Pharmacies
  • Table 262. Nigeria: Sickle Cell Disease Treatment Market Revenue and Forecast to 2030 (US$ Mn) - Distribution Channel
  • Table 263. Nigeria: Sickle Cell Disease Treatment Market Revenue and Forecast to 2030 (US$ Mn) - Hospital Pharmacies
  • Table 264. Nigeria: Sickle Cell Disease Treatment Market Revenue and Forecast to 2030 (US$ Mn) - Distribution Channel
  • Table 265. Ghana: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn) - Treatment
  • Table 266. Ghana: Sickle Cell Disease Treatment Market Revenue and Forecast to 2030 (US$ Mn) - Treatment
  • Table 267. Ghana: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn) - Route of Administration
  • Table 268. Ghana: Sickle Cell Disease Treatment Market Revenue and Forecast to 2030 (US$ Mn) - Route of Administration
  • Table 269. Ghana: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn) - Distribution Channel
  • Table 270. Ghana: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn) - Hospital Pharmacies
  • Table 271. Ghana: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn) - Retail Pharmacies
  • Table 272. Ghana: Sickle Cell Disease Treatment Market Revenue and Forecast to 2030 (US$ Mn) - Distribution Channel
  • Table 273. Ghana: Sickle Cell Disease Treatment Market Revenue and Forecast to 2030 (US$ Mn) - Hospital Pharmacies
  • Table 274. Ghana: Sickle Cell Disease Treatment Market Revenue and Forecast to 2030 (US$ Mn) - Distribution Channel
  • Table 275. Uganda: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn) - Treatment
  • Table 276. Uganda: Sickle Cell Disease Treatment Market Revenue and Forecast to 2030 (US$ Mn) - Treatment
  • Table 277. Uganda: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn) - Route of Administration
  • Table 278. Uganda: Sickle Cell Disease Treatment Market Revenue and Forecast to 2030 (US$ Mn) - Route of Administration
  • Table 279. Uganda: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn) - Distribution Channel
  • Table 280. Uganda: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn) - Hospital Pharmacies
  • Table 281. Uganda: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn) - Retail Pharmacies
  • Table 282. Uganda: Sickle Cell Disease Treatment Market Revenue and Forecast to 2030 (US$ Mn) - Distribution Channel
  • Table 283. Uganda: Sickle Cell Disease Treatment Market Revenue and Forecast to 2030 (US$ Mn) - Hospital Pharmacies
  • Table 284. Uganda: Sickle Cell Disease Treatment Market Revenue and Forecast to 2030 (US$ Mn) - Distribution Channel
  • Table 285. Angola: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn) - Treatment
  • Table 286. Angola: Sickle Cell Disease Treatment Market Revenue and Forecast to 2030 (US$ Mn) - Treatment
  • Table 287. Angola: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn) - Route of Administration
  • Table 288. Angola: Sickle Cell Disease Treatment Market Revenue and Forecast to 2030 (US$ Mn) - Route of Administration
  • Table 289. Angola: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn) - Distribution Channel
  • Table 290. Angola: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn) - Hospital Pharmacies
  • Table 291. Angola: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn) - Retail Pharmacies
  • Table 292. Angola: Sickle Cell Disease Treatment Market Revenue and Forecast to 2030 (US$ Mn) - Distribution Channel
  • Table 293. Angola: Sickle Cell Disease Treatment Market Revenue and Forecast to 2030 (US$ Mn) - Hospital Pharmacies
  • Table 294. Angola: Sickle Cell Disease Treatment Market Revenue and Forecast to 2030 (US$ Mn) - Distribution Channel
  • Table 295. Cameroon: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn) - Treatment
  • Table 296. Cameroon: Sickle Cell Disease Treatment Market Revenue and Forecast to 2030 (US$ Mn) - Treatment
  • Table 297. Cameroon: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn) - Route of Administration
  • Table 298. Cameroon: Sickle Cell Disease Treatment Market Revenue and Forecast to 2030 (US$ Mn) - Route of Administration
  • Table 299. Cameroon: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn) - Distribution Channel
  • Table 300. Cameroon:

List Of Figures

  • Figure 1. PEST Analysis - Malaria
  • Figure 2. PEST Analysis - Sickle Cell Disease Treatment
  • Figure 3. Malaria and Sickle Cell Disease Treatment Market - Key Industry Dynamics
  • Figure 4. Impact Analysis of Drivers and Restraints
  • Figure 5. Malaria Treatment Market Revenue (US$ million), 2020 - 2030
  • Figure 6. Sickle Cell Disease Treatment Market Revenue (US$ million), 2020 - 2030
  • Figure 7. Malaria: Geography Analysis Market Revenue (US$ million), 2022 - 2030
  • Figure 8. Sickle Cell Disease: Geography Analysis Market Revenue (US$ million), 2022 - 2030
  • Figure 9. Malaria Treatment Market Revenue Share, by Treatment 2022 & 2030 (%)
  • Figure 10. Sickle Cell Disease Treatment Market Revenue Share, by Treatment 2022 & 2030 (%)
  • Figure 11. Malaria Treatment Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 12. Sickle Cell Disease Treatment Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 13. Malaria Treatment Market Revenue Share, by Route of Administration 2022 & 2030 (%)
  • Figure 14. Sickle Cell Disease Market Revenue Share, by Route of Administration 2022 & 2030 (%)
  • Figure 15. Oral: Malaria Treatment Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 16. Oral: Sickle Cell Disease Treatment Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 17. Parenteral: Malaria and Sickle Cell Disease Treatment Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 18. Parenteral: Sickle Cell Disease Treatment Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 19. Malaria Treatment Market Revenue Share, by Distribution Channel 2022 & 2030 (%)
  • Figure 20. Sickle Cell Disease Treatment Market Revenue Share, by Distribution Channel 2022 & 2030 (%)
  • Figure 21. Direct Tender: Malaria Treatment Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 22. Direct Tender: Sickle Cell Disease Treatment Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 23. Hospital Pharmacies: Malaria Treatment Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 24. Hospital Pharmacies: Sickle Cell Disease Treatment Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 25. Retail Pharmacies: Malaria Treatment Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 26. Retail Pharmacies: Sickle Cell Disease Treatment Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 27. Online Pharmacies: Malaria Treatment Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 28. Online Pharmacies: Sickle Cell Disease Treatment Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 29. Online Pharmacies: Malaria Treatment Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 30. Others: Sickle Cell Disease Treatment Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 31. North America Malaria Treatment Market, By Geography, 2022 ($Mn)
  • Figure 32. North America Sickle Cell Disease Treatment Market, By Geography, 2022 ($Mn)
  • Figure 33. Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn)
  • Figure 34. Sickle Cell Disease Treatment Market Revenue and Forecast to 2030 (US$ Mn)
  • Figure 35. North America: Malaria Treatment Market, By Key Countries, 2022 And 2030 (%)
  • Figure 36. North America: Sickle Cell Disease Treatment Market, By Key Countries, 2022 And 2030 (%)
  • Figure 37. US: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn)
  • Figure 38. US: Sickle Cell Treatment Market Revenue and Forecast to 2030 (US$ Mn)
  • Figure 39. Canada: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn)
  • Figure 40. Canada: Sickle Cell Treatment Market Revenue and Forecast to 2030 (US$ Mn)
  • Figure 41. Mexico: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn)
  • Figure 42. Mexico: Sickle Cell Treatment Market Revenue and Forecast to 2030 (US$ Mn)
  • Figure 43. Europe Malaria Treatment Market, By Geography, 2022 ($Mn)
  • Figure 44. Europe Malaria and Sickle Cell Disease Treatment Market, By Geography, 2022 ($Mn)
  • Figure 45. Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn)
  • Figure 46. Sickle Cell Disease Treatment Market Revenue and Forecast to 2030 (US$ Mn)
  • Figure 47. Europe: Malaria Treatment Market, By Key Countries, 2022 And 2030 (%)
  • Figure 48. Europe: Sickle Cell Disease Treatment Market, By Key Countries, 2022 And 2030 (%)
  • Figure 49. France: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn)
  • Figure 50. France: Sickle Cell Treatment Market Revenue and Forecast to 2030 (US$ Mn)
  • Figure 51. UK: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn)
  • Figure 52. UK: Sickle Cell Treatment Market Revenue and Forecast to 2030 (US$ Mn)
  • Figure 53. Italy: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn)
  • Figure 54. Italy: Sickle Cell Treatment Market Revenue and Forecast to 2030 (US$ Mn)
  • Figure 55. Germany: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn)
  • Figure 56. Germany: Sickle Cell Treatment Market Revenue and Forecast to 2030 (US$ Mn)
  • Figure 57. Spain: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn)
  • Figure 58. Spain: Sickle Cell Treatment Market Revenue and Forecast to 2030 (US$ Mn)
  • Figure 59. Rest of Europe: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn)
  • Figure 60. Rest of Europe: Sickle Cell Treatment Market Revenue and Forecast to 2030 (US$ Mn)
  • Figure 61. Malaria Treatment Market, 2022 ($Mn)
  • Figure 62. Sickle Cell Disease Treatment Market, 2022 ($Mn)
  • Figure 63. Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn)
  • Figure 64. Sickle Cell Disease Treatment Market Revenue and Forecast to 2030 (US$ Mn)
  • Figure 65. Asia Pacific: Malaria Treatment Market, By Key Countries, 2022 And 2030 (%)
  • Figure 66. Asia Pacific: Sickle Cell Disease Treatment Market, By Key Countries, 2022 And 2030 (%)
  • Figure 67. China: Sickle Cell Treatment Market Revenue and Forecast to 2030 (US$ Mn)
  • Figure 68. Japan: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn)
  • Figure 69. Japan: Sickle Cell Treatment Market Revenue and Forecast to 2030 (US$ Mn)
  • Figure 70. India: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn)
  • Figure 71. India: Sickle Cell Treatment Market Revenue and Forecast to 2030 (US$ Mn)
  • Figure 72. South Korea: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn)
  • Figure 73. South Korea: Sickle Cell Treatment Market Revenue and Forecast to 2030 (US$ Mn)
  • Figure 74. Australia: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn)
  • Figure 75. Australia: Sickle Cell Treatment Market Revenue and Forecast to 2030 (US$ Mn)
  • Figure 76. Rest of Asia Pacific: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn)
  • Figure 77. Rest of Asia Pacific: Sickle Cell Treatment Market Revenue and Forecast to 2030 (US$ Mn)
  • Figure 78. Malaria Treatment Market, 2022 (US$ Mn)
  • Figure 79. Sickle Cell Disease Treatment Market, 2022 (US$ Mn)
  • Figure 80. Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn)
  • Figure 81. Sickle Cell Disease Treatment Market Revenue and Forecast to 2030 (US$ Mn)
  • Figure 82. Middle East & Africa: Malaria Treatment Market, By Key Countries, 2022 And 2030 (%)
  • Figure 83. Middle East & Africa: Sickle Cell Disease Treatment Market, By Key Countries, 2022 And 2030 (%)
  • Figure 84. Saudi Arabia: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn)
  • Figure 85. Saudi Arabia: Sickle Cell Treatment Market Revenue and Forecast to 2030 (US$ Mn)
  • Figure 86. UAE: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn)
  • Figure 87. UAE: Sickle Cell Treatment Market Revenue and Forecast to 2030 (US$ Mn)
  • Figure 88. South Africa: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn)
  • Figure 89. South Africa: Sickle Cell Treatment Market Revenue and Forecast to 2030 (US$ Mn)
  • Figure 90. Kenya: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn)
  • Figure 91. Kenya: Sickle Cell Treatment Market Revenue and Forecast to 2030 (US$ Mn)
  • Figure 92. Tanzania: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn)
  • Figure 93. Tanzania: Sickle Cell Treatment Market Revenue and Forecast to 2030 (US$ Mn)
  • Figure 94. Rwanda: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn)
  • Figure 95. Rwanda: Sickle Cell Treatment Market Revenue and Forecast to 2030 (US$ Mn)
  • Figure 96. Nigeria: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn)
  • Figure 97. Nigeria: Sickle Cell Treatment Market Revenue and Forecast to 2030 (US$ Mn)
  • Figure 98. Ghana: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn)
  • Figure 99. Ghana: Sickle Cell Treatment Market Revenue and Forecast to 2030 (US$ Mn)
  • Figure 100. Uganda: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn)
  • Figure 101. Uganda: Sickle Cell Treatment Market Revenue and Forecast to 2030 (US$ Mn)
  • Figure 102. Angola: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn)
  • Figure 103. Angola: Sickle Cell Treatment Market Revenue and Forecast to 2030 (US$ Mn)
  • Figure 104. Cameroon: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn)
  • Figure 105. Cameroon: Sickle Cell Treatment Market Revenue and Forecast to 2030 (US$ Mn)
  • Figure 106. Senegal: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn)
  • Figure 107. Senegal: Sickle Cell Treatment Market Revenue and Forecast to 2030 (US$ Mn)
  • Figure 108. Zambia: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn)
  • Figure 109. Zambia: Sickle Cell Treatment Market Revenue and Forecast to 2030 (US$ Mn)
  • Figure 110. Rest of Middle East & Africa: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn)
  • Figure 111. Rest of Middle East & Africa: Sickle Cell Treatment Market Revenue and Forecast to 2030 (US$ Mn)
  • Figure 112. Malaria Treatment Market, 2022 ($Mn)
  • Figure 113. Sickle Cell Disease Treatment Market, 2022 ($Mn)
  • Figure 114. Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn)
  • Figure 115. Sickle Cell Disease Treatment Market Revenue and Forecast to 2030 (US$ Mn)
  • Figure 116. Asia Pacific: Malaria Treatment Market, By Key Countries, 2022 And 2030 (%)
  • Figure 117. Asia Pacific: Sickle Cell Disease Treatment Market, By Key Countries, 2022 And 2030 (%)
  • Figure 118. China: Sickle Cell Treatment Market Revenue and Forecast to 2030 (US$ Mn)
  • Figure 119. Japan: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn)
  • Figure 120. Japan: Sickle Cell Treatment Market Revenue and Forecast to 2030 (US$ Mn)
  • Figure 121. India: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn)
  • Figure 122. India: Sickle Cell Treatment Market Revenue and Forecast to 2030 (US$ Mn)
  • Figure 123. South Korea: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn)
  • Figure 124. South Korea: Sickle Cell Treatment Market Revenue and Forecast to 2030 (US$ Mn)
  • Figure 125. Australia: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn)
  • Figure 126. Australia: Sickle Cell Treatment Market Revenue and Forecast to 2030 (US$ Mn)
  • Figure 127. Rest of Asia Pacific: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn)
  • Figure 128. Rest of Asia Pacific: Sickle Cell Treatment Market Revenue and Forecast to 2030 (US$ Mn)
  • Figure 129. Malaria Treatment Market, 2022 ($Mn)
  • Figure 130. Sickle Cell Disease Treatment Market, 2022 ($Mn)
  • Figure 131. Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn)
  • Figure 132. Sickle Cell Disease Treatment Market Revenue and Forecast to 2030 (US$ Mn)
  • Figure 133. South & Central America: Malaria Treatment Market, By Key Countries, 2022 And 2030 (%)
  • Figure 134. South & Central America: Sickle Cell Disease Treatment Market, By Key Countries, 2022 And 2030 (%)
  • Figure 135. Brazil: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn)
  • Figure 136. Brazil: Sickle Cell Treatment Market Revenue and Forecast to 2030 (US$ Mn)
  • Figure 137. Argentina: Sickle Cell Treatment Market Revenue and Forecast to 2030 (US$ Mn)
  • Figure 138. Rest of South & Central America: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn)
  • Figure 139. Rest of South & Central America: Sickle Cell Treatment Market Revenue and Forecast to 2030 (US$ Mn)
  • Figure 140. Growth Strategies in the Malaria and Sickle Cell Disease Treatment Market
目次
Product Code: TIPRE00030125

The malaria and sickle cell disease treatment market is expected to grow from US$ 4.457 billion in 2022 to US$ 29.179 billion by 2030; it is estimated to grow at a CAGR of 26.5% from 2022 to 2030. The market for malaria and sickle cell disease treatment is growing due to the increasing prevalence of malaria and sickle cell disease and rising government initiatives to raise awareness about malaria and SCD. However, factors such as a counterfeit antimalarial drug and subsequent drug resistance are restraining the market growth.

Antimicrobial resistance can put the public at risk of many diseases, such as malaria. To overcome this challenge, the R&D of new medicines is considered the best strategy; as a result, the antimalarial and SCD drug/vaccine pipeline is becoming increasingly robust. Public-private partnerships are accelerating research activities related to the treatment of malaria and sickle cell disease. For instance, Medicines for Malaria Venture (MMV), a nonprofit organization, works with numerous pharmaceutical companies to reduce the burden of malaria by developing novel treatment options.

A few antimalarial and SCD drugs/vaccines that are under clinical development are mentioned in the table below:

Table 1. Malaria Drugs/Vaccine/Compounds Under Clinical Development

DrugDeveloperClinical Trial Stage
ArtefenomelSanofiPhase IIb
KAE609Novartis AGPhase IIb
KAF156Novartis AGPhase IIb
DSM265Takeda Pharmaceutical CompanyPhase IIa
SANARIA PfSPZ-GA1SanariaPhase II
SANARIA PfSPZ Vaccine - Radiation Attenuated PfSPZ VaccineSanariaPhase II
SANARIA PfSPZ-CVacSanariaPhase II
MSP3-CRM-Vac4AllVac4AllPhase I
Liver-Stage Antigen-3 (LSA3)Vac4AllPhase IIa

            Source: Company Website, The Insight Partners Analysis.

Table 2. Sickle Cell Disease Drugs/Vaccine/Compounds Under Clinical Development

DrugDeveloperClinical Trial Stage
InclacumabPfizerPhase III
VoxelotorPfizerPhase III
GBT021601PfizerPhase II
PF-07209326PfizerPhase II
RG6107RochePhase II
GSK4172239DGSKPhase I
BEAM¬-101Beam TherapeuticsPhase I/II
HGB-206Bluebird Bio, Inc.Phase I/II
HGB-210Bluebird Bio, Inc.Phase III
ALXN1820AlexionPhase II
NCT05714969Takeda Pharmaceutical Company LimitedPhase 2b
NCT03997760Takeda Pharmaceutical Company LimitedPhase I

            Source: Company Website, The Insight Partners Analysis.

Therefore, the growing number of antimalarial and SCD drugs/vaccines that are under clinical development are expected to boost the market growth in the future.

The report segments the malaria and sickle cell disease treatment market as follows:

The malaria and sickle cell disease (SCD) treatment market is segmented on the basis of treatment, route of administration, distribution channel, and geography. Based on treatment, the market is divided into malaria and sickle cell disease. In terms of route of administration, the malaria and sickle cell disease (SCD) treatment market is divided into oral and parenteral. Based on distribution channel, the market is categorized into direct tender, hospital pharmacies, retail pharmacies, online pharmacies, and others. By geography, the malaria and sickle cell disease treatment market is segmented into North America (the US, Canada, and Mexico), Europe (the UK, Germany, France, Italy, Spain, and Rest of Europe), Asia Pacific (China, Japan, India, Australia, South Korea, and Rest of Asia Pacific), the Middle East & Africa (Saudi Arabia, the UAE, South Africa, Kenya, Tanzania, Rwanda, Nigeria, Ghana, Uganda, Angola, Cameroon, Senegal, Zambia, and Rest of the Middle East & Africa), and South & Central America (Brazil, Argentina, and Rest of South & Central America).

Route of Administration-Based Insights:

By route of administration, the malaria treatment market is bifurcated into oral and parenteral. In 2022, the oral segment held a larger market share, and the parenteral segment is estimated to record a faster CAGR during 2020-2030. Oral drug delivery is the most ideal and suitable route of drug administration as it offers high patient compliance, non-invasiveness, least sterility constraints, cost-effectiveness, flexibility in the design of dosage form, and ease in the manufacturing process. Benefits such as ease of administration and long-term cost efficiency are the major factors fueling the adoption of oral drugs.

Distribution Channel-Based Insights:

Based on distribution channel, the malaria and sickle cell disease (SCD) treatment market is segmented into direct tender, hospital pharmacies, retail pharmacies, online pharmacies, and others. The direct tender segment held the largest market share in 2022. A tender is an offer to do specific duties or provide items for a fixed amount. In the first step of a tender procedure, contractors will be asked to submit sealed bids for construction or to offer particularly planned services or products within a specific time limit. The e-tendering procedure in India is designed to ensure that work for the government or a specific client is completed in a timely manner.

A few of the major primary and secondary sources referred to while preparing the report on the malaria and sickle cell disease treatment market are the World Health Organization (WHO), the US Census Bureau, and CDC, among others.

Reasons to Buy:

  • Save and reduce time carrying out entry-level research by identifying the growth, size, leading players, and segments in the malaria and sickle cell disease (SCD) treatment market.
  • Highlights key business priorities in order to assist companies to realign their business strategies.
  • The key findings and recommendations highlight crucial progressive industry trends in the global malaria and sickle cell disease (SCD) treatment market, thereby allowing players across the value chain to develop effective long-term strategies.
  • Develop/modify business expansion plans by using substantial growth offering developed and emerging markets.
  • Scrutinize in-depth global market trends and outlook coupled with the factors driving the market, as well as those hindering it.
  • Enhance the decision-making process by understanding the strategies that underpin security interest with respect to client products, segmentation, pricing, and distribution.

Table of Contents

1. Introduction

  • 1.1. The Insight Partners Research Report Guidance
  • 1.2. Market Segmentation

2. Executive Summary

  • 2.1. Key Insights - Malaria
  • 2.2. Key Insights-Sickle Cell Disease

3. Research Methodology

  • 3.1. Coverage
  • 3.2. Secondary Research
  • 3.3. Primary Research

4. Malaria and Sickle Cell Disease Treatment Market Landscape

  • 4.1. Overview
  • 4.2. PEST Analysis-Malaria Treatment
  • 4.3. PEST Analysis-Sickle Cell Disease Treatment

5. Malaria and Sickle Cell Disease Treatment Market - Key Industry Dynamics

  • 5.1. Key Market Drivers:
    • 5.1.1. Increasing Prevalence of Malaria and Sickle Cell Disease
    • 5.1.2. Rising Initiatives to Raise Awareness about Malaria and SCD
  • 5.2. Market Restraints
    • 5.2.1. Lack of Sickle Cell Disease Treatment Options and Availability of Counterfeit Antimalarial Drugs Followed by Subsequent Drug Resistance
  • 5.3. Market Opportunities
    • 5.3.1. Growing Strategic Initiatives by Market Players
  • 5.4. Future Trends
    • 5.4.1. Extending Pipeline of New Drugs and Vaccines
  • 5.5. Impact Analysis

6. Malaria and Sickle Cell Disease Treatment Market - Global Market Analysis

  • 6.1. Malaria Treatment Market Revenue (US$ million), 2022-2030
  • 6.2. Sickle Cell Disease Treatment Market Revenue (US$ million), 2022-2030
  • 6.3. Geography Analysis Market Revenue (US$ million), 2022-2030
  • 6.4. Epidemiology Data for Malaria
    • 6.4.1. Malaria Transmission Characteristics, Immunity, and Clinical Features
    • 6.4.2. Estimated Malaria Cases and Deaths
      • 6.4.2.1. Fundings for Malaria-Related R&D, 2021
      • 6.4.2.2. Fundings for Malaria Control, 2021
  • 6.5. Funding Allocation Mechanism
    • 6.5.1. Global Funds
      • 6.5.1.1. USAID: Burundi-Malaria Operational Plan FY 2022
      • 6.5.1.2. Procurement Scenario For Malaria Drugs
  • 6.6. Reimbursement Scenario for Malaria
    • 6.6.1. Overview
  • 6.7. Sickle Cell Disease
    • 6.7.1.1. Epidemiology Data of Sickle Cell Disease (SCD), 2020
  • 6.8. Fundings for Sickle Cell Disease (SCD)
  • 6.9. Reimbursement Scenario for Sickle Cell Disease
    • 6.9.1. Overview
  • 6.10. Number of Healthcare Facilities and Healthcare Expenditure:

7. Malaria and Sickle Cell Disease Treatment Market-Revenue and Forecast to 2030-by Treatment

  • 7.1. Overview
  • 7.2. Malaria Treatment Market Revenue Share, by Treatment 2022 & 2030 (%)
  • 7.3. Overview
  • 7.4. Sickle Cell Disease Treatment Market Revenue Share, by Treatment 2022 & 2030 (%)
  • 7.5. Malaria
    • 7.5.1. Overview
    • 7.5.2. Malaria Treatment Market-Revenue and Forecast to 2030 (US$ Million)
      • 7.5.2.1. Malaria Treatment Market, by Treatment
  • 7.6. Sickle Cell Disease (SCD)
    • 7.6.1. Overview
    • 7.6.2. Sickle Cell Disease Treatment Market-Revenue and Forecast to 2030 (US$ Million)
      • 7.6.2.1. Sickle Cell Disease Treatment Market, by Treatment

8. Malaria and Sickle Cell Disease Treatment Market-Revenue and Forecast to 2030-by Route of Administration

  • 8.1. Overview
  • 8.2. Malaria Treatment Market Revenue Share, by Route of Administration 2022 & 2030 (%)
  • 8.3. Overview
  • 8.4. Sickle Cell Disease Treatment Market Revenue Share, by Route of Administration 2022 & 2030 (%)
  • 8.5. Oral
    • 8.5.1. Overview
    • 8.5.2. Oral: Malaria Treatment Market-Revenue and Forecast to 2030 (US$ Million)
    • 8.5.3. Oral: Sickle Cell Disease Treatment Market-Revenue and Forecast to 2030 (US$ Million)
  • 8.6. Parenteral
    • 8.6.1. Overview
    • 8.6.2. Parenteral: Malaria Treatment Market-Revenue and Forecast to 2030 (US$ Million)
    • 8.6.3. Parenteral: Sickle Cell Disease Treatment Market-Revenue and Forecast to 2030 (US$ Million)

9. Malaria and Sickle Cell Disease Treatment Market-Revenue and Forecast to 2030-by Distribution Channel

  • 9.1. Overview
  • 9.2. Malaria Treatment Market Revenue Share, by Distribution Channel 2022 & 2030 (%)
  • 9.3. Overview
  • 9.4. Sickle Cell Disease Treatment Market Revenue Share, by Distribution Channel 2022 & 2030 (%)
  • 9.5. Direct Tender
    • 9.5.1. Overview
    • 9.5.2. Direct Tender: Malaria Treatment Market-Revenue and Forecast to 2030 (US$ Million)
    • 9.5.3. Direct Tender: Sickle Cell Disease Treatment Market-Revenue and Forecast to 2030 (US$ Million)
  • 9.6. Hospital Pharmacies
    • 9.6.1. Overview
    • 9.6.2. Hospital Pharmacies: Malaria Market-Revenue and Forecast to 2030 (US$ Million)
      • 9.6.2.1.1. Malaria Treatment Market, by Hospital Pharmacies
    • 9.6.3. Hospital Pharmacies: Sickle Cell Disease Treatment Market-Revenue and Forecast to 2030 (US$ Million)
      • 9.6.3.1.1. Sickle Cell Disease Treatment Market, by Hospital Pharmacies
  • 9.7. Retail Pharmacies
    • 9.7.1. Overview
    • 9.7.2. Retail Pharmacies: Malaria Treatment Market-Revenue and Forecast to 2030 (US$ Million)
      • 9.7.2.1.1. Malaria Treatment Market, by Retail Pharmacies
    • 9.7.3. Retail Pharmacies: Sickle Cell Disease Treatment Market-Revenue and Forecast to 2030 (US$ Million)
      • 9.7.3.1.1. Sickle Cell Disease Treatment Market, by Retail Pharmacies
  • 9.8. Online Pharmacies
    • 9.8.1. Overview
    • 9.8.2. Online Pharmacies: Malaria Treatment Market-Revenue and Forecast to 2030 (US$ Million)
    • 9.8.3. Online Pharmacies: Sickle Cell Disease Treatment Market-Revenue and Forecast to 2030 (US$ Million)
  • 9.9. Others
    • 9.9.1. Overview
    • 9.9.2. Others : Malaria Treatment Market-Revenue and Forecast to 2030 (US$ Million)
    • 9.9.3. Others: Sickle Cell Disease Treatment Market-Revenue and Forecast to 2030 (US$ Million)

10. Malaria and Sickle Cell Disease Treatment Market - Geographical Analysis

  • 10.1. North America Malaria and Sickle Cell Disease Treatment Market, Revenue and Forecast To 2030
    • 10.1.1. Overview
    • 10.1.2. Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn)
    • 10.1.3. Sickle Cell Disease Treatment Market Revenue and Forecast to 2030 (US$ Mn)
      • 10.1.3.1. North America: Malaria Treatment Market, by Treatment
      • 10.1.3.2. North America: Sickle Cell Disease Treatment Market, by Treatment
      • 10.1.3.3. North America: Malaria Treatment Market, by Route of Administration
      • 10.1.3.4. North America: Sickle Cell Disease Treatment Market, by Route of Administration
      • 10.1.3.5. North America: Malaria Treatment Market, by Distribution Channel
        • 10.1.3.5.1. North America: Malaria Treatment Market, by Hospital Pharmacies
        • 10.1.3.5.2. North America: Malaria Treatment Market, by Retail Pharmacies
      • 10.1.3.6. North America: Sickle Cell Treatment Market, by Distribution Channel
        • 10.1.3.6.1. North America: Sickle Cell Treatment Market, by Hospital Pharmacies
        • 10.1.3.6.2. North America: Sickle Cell Treatment Market, by Retail Pharmacies
      • 10.1.3.7. North America: Malaria Treatment Market, by Country
      • 10.1.3.8. North America: Sickle Cell Disease Treatment Market, by Country
      • 10.1.3.9. US
      • 10.1.3.10. Overview
        • 10.1.3.10.1. US: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn)
        • 10.1.3.10.2. US: Sickle Cell Disease Treatment Market Revenue and Forecast to 2030 (US$ Mn)
        • 10.1.3.10.3. US: Malaria Treatment Market, by Treatment
        • 10.1.3.10.4. US: Sickle Cell Disease Treatment Market, by Treatment
        • 10.1.3.10.5. US: Malaria -Malaria Treatment Market, by Route of Administration
        • 10.1.3.10.6. US: Sickle Cell Disease Treatment Market, by Route of Administration
        • 10.1.3.10.7. US: Malaria Treatment Market, by Distribution Channel
          • 10.1.3.10.7.1. US: Malaria Treatment Market, by Hospital Pharmacies
          • 10.1.3.10.7.2. US: Malaria Treatment Market, by Retail Pharmacies
        • 10.1.3.10.8. US: Sickle Cell Disease Treatment Market, by Distribution Channel
          • 10.1.3.10.8.1. US: Sickle Cell Disease Treatment Market, by Hospital Pharmacies
          • 10.1.3.10.8.2. US: Sickle Cell Disease Treatment Market, by Retail Pharmacies
      • 10.1.3.11. Canada
      • 10.1.3.12. Overview
        • 10.1.3.12.1. Canada: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn)
        • 10.1.3.12.2. Canada: Sickle Cell Disease Treatment Market Revenue and Forecast to 2030 (US$ Mn)
        • 10.1.3.12.3. Canada: Malaria Treatment Market, by Treatment
        • 10.1.3.12.4. Canada: Sickle Cell Disease Treatment Market, by Treatment
        • 10.1.3.12.5. Canada: Malaria -Malaria Treatment Market, by Route of Administration
        • 10.1.3.12.6. Canada: Sickle Cell Disease Treatment Market, by Route of Administration
        • 10.1.3.12.7. Canada: Malaria Treatment Market, by Distribution Channel
          • 10.1.3.12.7.1. Canada: Malaria Treatment Market, by Hospital Pharmacies
          • 10.1.3.12.7.2. Canada: Malaria Treatment Market, by Retail Pharmacies
        • 10.1.3.12.8. Canada: Sickle Cell Disease Treatment Market, by Distribution Channel
          • 10.1.3.12.8.1. Canada: Sickle Cell Disease Treatment Market, by Hospital Pharmacies
          • 10.1.3.12.8.2. Canada: Sickle Cell Disease Treatment Market, by Retail Pharmacies
      • 10.1.3.13. Mexico
      • 10.1.3.14. Overview
        • 10.1.3.14.1. Mexico: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn)
        • 10.1.3.14.2. Mexico: Sickle Cell Disease Treatment Market Revenue and Forecast to 2030 (US$ Mn)
        • 10.1.3.14.3. Mexico: Malaria Treatment Market, by Treatment
        • 10.1.3.14.4. Mexico: Sickle Cell Disease Treatment Market, by Treatment
        • 10.1.3.14.5. Mexico: Malaria -Malaria Treatment Market, by Route of Administration
        • 10.1.3.14.6. Mexico: Sickle Cell Disease Treatment Market, by Route of Administration
        • 10.1.3.14.7. Mexico: Malaria Treatment Market, by Distribution Channel
          • 10.1.3.14.7.1. Mexico: Malaria Treatment Market, by Hospital Pharmacies
          • 10.1.3.14.7.2. Mexico: Malaria Treatment Market, by Retail Pharmacies
        • 10.1.3.14.8. Mexico: Sickle Cell Disease Treatment Market, by Distribution Channel
          • 10.1.3.14.8.1. Mexico: Sickle Cell Disease Treatment Market, by Hospital Pharmacies
          • 10.1.3.14.8.2. Mexico: Sickle Cell Disease Treatment Market, by Retail Pharmacies
  • 10.2. Europe Malaria and Sickle Cell Disease Treatment Market, Revenue and Forecast To 2030
    • 10.2.1. Overview
    • 10.2.2. Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn)
    • 10.2.3. Sickle Cell Disease Treatment Market Revenue and Forecast to 2030 (US$ Mn)
      • 10.2.3.1. Europe: Malaria Treatment Market, by Treatment
      • 10.2.3.2. Europe: Sickle Cell Disease Treatment Market, by Treatment
      • 10.2.3.3. Europe: Malaria Treatment Market, by Route of Administration
      • 10.2.3.4. Europe: Sickle Cell Disease Treatment Market, by Route of Administration
      • 10.2.3.5. Europe: Malaria Treatment Market, by Distribution Channel
        • 10.2.3.5.1. Europe: Malaria Treatment Market, by Hospital Pharmacies
        • 10.2.3.5.2. Europe: Malaria Treatment Market, by Retail Pharmacies
      • 10.2.3.6. Europe: Sickle Cell Treatment Market, by Distribution Channel
        • 10.2.3.6.1. Europe: Sickle Cell Treatment Market, by Hospital Pharmacies
        • 10.2.3.6.2. Europe: Sickle Cell Treatment Market, by Retail Pharmacies
      • 10.2.3.7. Europe: Malaria Treatment Market, by Countries
      • 10.2.3.8. Europe: Sickle Cell Disease Treatment Market, by Countries
      • 10.2.3.9. France
      • 10.2.3.10. Overview
        • 10.2.3.10.1. France: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn)
        • 10.2.3.10.2. France: Sickle Cell Disease Treatment Market Revenue and Forecast to 2030 (US$ Mn)
        • 10.2.3.10.3. France: Malaria Treatment Market, by Treatment
        • 10.2.3.10.4. France: Sickle Cell Disease Treatment Market, by Treatment
        • 10.2.3.10.5. France: Malaria -Malaria Treatment Market, by Route of Administration
        • 10.2.3.10.6. France: Sickle Cell Disease Treatment Market, by Route of Administration
        • 10.2.3.10.7. France: Malaria Treatment Market, by Distribution Channel
          • 10.2.3.10.7.1. France: Malaria Treatment Market, by Hospital Pharmacies
          • 10.2.3.10.7.2. France: Malaria Treatment Market, by Retail Pharmacies
        • 10.2.3.10.8. France: Sickle Cell Disease Treatment Market, by Distribution Channel
          • 10.2.3.10.8.1. France: Sickle Cell Disease Treatment Market, by Hospital Pharmacies
          • 10.2.3.10.8.2. France: Sickle Cell Disease Treatment Market, by Retail Pharmacies
      • 10.2.3.11. UK
      • 10.2.3.12. Overview
        • 10.2.3.12.1. UK: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn)
        • 10.2.3.12.2. UK: Sickle Cell Disease Treatment Market Revenue and Forecast to 2030 (US$ Mn)
        • 10.2.3.12.3. UK: Malaria Treatment Market, by Treatment
        • 10.2.3.12.4. UK: Sickle Cell Disease Treatment Market, by Treatment
        • 10.2.3.12.5. UK: Malaria -Malaria Treatment Market, by Route of Administration
        • 10.2.3.12.6. UK: Sickle Cell Disease Treatment Market, by Route of Administration
        • 10.2.3.12.7. UK: Malaria Treatment Market, by Distribution Channel
          • 10.2.3.12.7.1. UK: Malaria Treatment Market, by Hospital Pharmacies
          • 10.2.3.12.7.2. UK: Malaria Treatment Market, by Retail Pharmacies
        • 10.2.3.12.8. UK: Sickle Cell Disease Treatment Market, by Distribution Channel
          • 10.2.3.12.8.1. UK: Sickle Cell Disease Treatment Market, by Hospital Pharmacies
          • 10.2.3.12.8.2. UK: Sickle Cell Disease Treatment Market, by Retail Pharmacies
      • 10.2.3.13. Italy
      • 10.2.3.14. Overview
        • 10.2.3.14.1. Italy: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn)
        • 10.2.3.14.2. Italy: Sickle Cell Disease Treatment Market Revenue and Forecast to 2030 (US$ Mn)
        • 10.2.3.14.3. Italy: Malaria Treatment Market, by Treatment
        • 10.2.3.14.4. Italy: Sickle Cell Disease Treatment Market, by Treatment
        • 10.2.3.14.5. Italy: Malaria -Malaria Treatment Market, by Route of Administration
        • 10.2.3.14.6. Italy: Sickle Cell Disease Treatment Market, by Route of Administration
        • 10.2.3.14.7. Italy: Malaria Treatment Market, by Distribution Channel
          • 10.2.3.14.7.1. Italy: Malaria Treatment Market, by Hospital Pharmacies
          • 10.2.3.14.7.2. Italy: Malaria Treatment Market, by Retail Pharmacies
        • 10.2.3.14.8. Italy: Sickle Cell Disease Treatment Market, by Distribution Channel
          • 10.2.3.14.8.1. Italy: Sickle Cell Disease Treatment Market, by Hospital Pharmacies
          • 10.2.3.14.8.2. Italy: Sickle Cell Disease Treatment Market, by Retail Pharmacies
      • 10.2.3.15. Germany
      • 10.2.3.16. Overview
        • 10.2.3.16.1. Germany: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn)
        • 10.2.3.16.2. Germany: Sickle Cell Disease Treatment Market Revenue and Forecast to 2030 (US$ Mn)
        • 10.2.3.16.3. Germany: Malaria Treatment Market, by Treatment
        • 10.2.3.16.4. Germany: Sickle Cell Disease Treatment Market, by Treatment
        • 10.2.3.16.5. Germany: Malaria -Malaria Treatment Market, by Route of Administration
        • 10.2.3.16.6. Germany: Sickle Cell Disease Treatment Market, by Route of Administration
        • 10.2.3.16.7. Germany: Malaria Treatment Market, by Distribution Channel
          • 10.2.3.16.7.1. Germany: Malaria Treatment Market, by Hospital Pharmacies
          • 10.2.3.16.7.2. Germany: Malaria Treatment Market, by Retail Pharmacies
        • 10.2.3.16.8. Germany: Sickle Cell Disease Treatment Market, by Distribution Channel
          • 10.2.3.16.8.1. Germany: Sickle Cell Disease Treatment Market, by Hospital Pharmacies
          • 10.2.3.16.8.2. Germany: Sickle Cell Disease Treatment Market, by Retail Pharmacies
      • 10.2.3.17. Spain
      • 10.2.3.18. Overview
        • 10.2.3.18.1. Spain: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn)
        • 10.2.3.18.2. Spain: Sickle Cell Disease Treatment Market Revenue and Forecast to 2030 (US$ Mn)
        • 10.2.3.18.3. Spain: Malaria Treatment Market, by Treatment
        • 10.2.3.18.4. Spain: Sickle Cell Disease Treatment Market, by Treatment
        • 10.2.3.18.5. Spain: Malaria -Malaria Treatment Market, by Route of Administration
        • 10.2.3.18.6. Spain: Sickle Cell Disease Treatment Market, by Route of Administration
        • 10.2.3.18.7. Spain: Malaria Treatment Market, by Distribution Channel
          • 10.2.3.18.7.1. Spain: Malaria Treatment Market, by Hospital Pharmacies
          • 10.2.3.18.7.2. Spain: Malaria Treatment Market, by Retail Pharmacies
        • 10.2.3.18.8. Spain: Sickle Cell Disease Treatment Market, by Distribution Channel
          • 10.2.3.18.8.1. Spain: Sickle Cell Disease Treatment Market, by Hospital Pharmacies
          • 10.2.3.18.8.2. Spain: Sickle Cell Disease Treatment Market, by Retail Pharmacies
      • 10.2.3.19. Rest of Europe
      • 10.2.3.20. Overview
        • 10.2.3.20.1. Rest of Europe: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn)
        • 10.2.3.20.2. Rest of Europe: Sickle Cell Disease Treatment Market Revenue and Forecast to 2030 (US$ Mn)
        • 10.2.3.20.3. Rest of Europe: Malaria Treatment Market, by Treatment
        • 10.2.3.20.4. Rest of Europe: Sickle Cell Disease Treatment Market, by Treatment
        • 10.2.3.20.5. Rest of Europe: Malaria -Malaria Treatment Market, by Route of Administration
        • 10.2.3.20.6. Rest of Europe: Sickle Cell Disease Treatment Market, by Route of Administration
        • 10.2.3.20.7. Rest of Europe: Malaria Treatment Market, by Distribution Channel
          • 10.2.3.20.7.1. Rest of Europe: Malaria Treatment Market, by Hospital Pharmacies
          • 10.2.3.20.7.2. Rest of Europe: Malaria Treatment Market, by Retail Pharmacies
        • 10.2.3.20.8. Rest of Europe: Sickle Cell Disease Treatment Market, by Distribution Channel
          • 10.2.3.20.8.1. Rest of Europe: Sickle Cell Disease Treatment Market, by Hospital Pharmacies
          • 10.2.3.20.8.2. Rest of Europe: Sickle Cell Disease Treatment Market, by Retail Pharmacies
  • 10.3. Asia Pacific Malaria and Sickle Cell Disease Treatment Market, Revenue and Forecast To 2030
    • 10.3.1. Overview
    • 10.3.2. Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn)
    • 10.3.3. Sickle Cell Disease Treatment Market Revenue and Forecast to 2030 (US$ Mn)
      • 10.3.3.1. Asia Pacific: Malaria Treatment Market, by Treatment
      • 10.3.3.2. Asia Pacific: Sickle Cell Disease Treatment Market, by Treatment
      • 10.3.3.3. Asia Pacific: Malaria Treatment Market, by Route of Administration
      • 10.3.3.4. Asia Pacific: Sickle Cell Disease Treatment Market, by Route of Administration
      • 10.3.3.5. Asia Pacific: Malaria Treatment Market, by Distribution Channel
        • 10.3.3.5.1. Asia Pacific: Malaria Treatment Market, by Hospital Pharmacies
        • 10.3.3.5.2. Asia Pacific: Malaria Treatment Market, by Retail Pharmacies
      • 10.3.3.6. Asia Pacific: Sickle Cell Treatment Market, by Distribution Channel
        • 10.3.3.6.1. Asia Pacific: Sickle Cell Treatment Market, by Hospital Pharmacies
        • 10.3.3.6.2. Asia Pacific: Sickle Cell Treatment Market, by Retail Pharmacies
      • 10.3.3.7. Asia Pacific: Malaria Treatment Market, by Countries
      • 10.3.3.8. Asia Pacific: Sickle Cell Disease Treatment Market, by Country
      • 10.3.3.9. China
      • 10.3.3.10. Overview
        • 10.3.3.10.1. China: Sickle Cell Disease Treatment Market Revenue and Forecast to 2030 (US$ Mn)
        • 10.3.3.10.2. China: Sickle Cell Disease Treatment Market, by Treatment
        • 10.3.3.10.3. China: Sickle Cell Disease Treatment Market, by Route of Administration
        • 10.3.3.10.4. China: Sickle Cell Disease Treatment Market, by Distribution Channel
          • 10.3.3.10.4.1. China: Sickle Cell Disease Treatment Market, by Hospital Pharmacies
          • 10.3.3.10.4.2. China: Sickle Cell Disease Treatment Market, by Retail Pharmacies
      • 10.3.3.11. Japan
      • 10.3.3.12. Overview
        • 10.3.3.12.1. Japan: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn)
        • 10.3.3.12.2. Japan: Sickle Cell Disease Treatment Market Revenue and Forecast to 2030 (US$ Mn)
        • 10.3.3.12.3. Japan: Malaria Treatment Market, by Treatment
        • 10.3.3.12.4. Japan: Sickle Cell Disease Treatment Market, by Treatment
        • 10.3.3.12.5. Japan: Malaria -Malaria Treatment Market, by Route of Administration
        • 10.3.3.12.6. Japan: Sickle Cell Disease Treatment Market, by Route of Administration
        • 10.3.3.12.7. Japan: Malaria Treatment Market, by Distribution Channel
          • 10.3.3.12.7.1. Japan: Malaria Treatment Market, by Hospital Pharmacies
          • 10.3.3.12.7.2. Japan: Malaria Treatment Market, by Retail Pharmacies
        • 10.3.3.12.8. Japan: Sickle Cell Disease Treatment Market, by Distribution Channel
          • 10.3.3.12.8.1. Japan: Sickle Cell Disease Treatment Market, by Hospital Pharmacies
          • 10.3.3.12.8.2. Japan: Sickle Cell Disease Treatment Market, by Retail Pharmacies
      • 10.3.3.13. India
      • 10.3.3.14. Overview
        • 10.3.3.14.1. India: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn)
        • 10.3.3.14.2. India: Sickle Cell Disease Treatment Market Revenue and Forecast to 2030 (US$ Mn)
        • 10.3.3.14.3. India: Malaria Treatment Market, by Treatment
        • 10.3.3.14.4. India: Sickle Cell Disease Treatment Market, by Treatment
        • 10.3.3.14.5. India: Malaria -Malaria Treatment Market, by Route of Administration
        • 10.3.3.14.6. India: Sickle Cell Disease Treatment Market, by Route of Administration
        • 10.3.3.14.7. India: Malaria Treatment Market, by Distribution Channel
          • 10.3.3.14.7.1. India: Malaria Treatment Market, by Hospital Pharmacies
          • 10.3.3.14.7.2. India: Malaria Treatment Market, by Retail Pharmacies
        • 10.3.3.14.8. India: Sickle Cell Disease Treatment Market, by Distribution Channel
          • 10.3.3.14.8.1. India: Sickle Cell Disease Treatment Market, by Hospital Pharmacies
          • 10.3.3.14.8.2. India: Sickle Cell Disease Treatment Market, by Retail Pharmacies
      • 10.3.3.15. South Korea
      • 10.3.3.16. Overview
        • 10.3.3.16.1. South Korea: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn)
        • 10.3.3.16.2. South Korea: Sickle Cell Disease Treatment Market Revenue and Forecast to 2030 (US$ Mn)
        • 10.3.3.16.3. South Korea: Malaria Treatment Market, by Treatment
        • 10.3.3.16.4. South Korea: Sickle Cell Disease Treatment Market, by Treatment
        • 10.3.3.16.5. South Korea: Malaria -Malaria Treatment Market, by Route of Administration
        • 10.3.3.16.6. South Korea: Sickle Cell Disease Treatment Market, by Route of Administration
        • 10.3.3.16.7. South Korea: Malaria Treatment Market, by Distribution Channel
          • 10.3.3.16.7.1. South Korea: Malaria Treatment Market, by Hospital Pharmacies
          • 10.3.3.16.7.2. South Korea: Malaria Treatment Market, by Retail Pharmacies
        • 10.3.3.16.8. South Korea: Sickle Cell Disease Treatment Market, by Distribution Channel
          • 10.3.3.16.8.1. South Korea: Sickle Cell Disease Treatment Market, by Hospital Pharmacies
          • 10.3.3.16.8.2. South Korea: Sickle Cell Disease Treatment Market, by Retail Pharmacies
      • 10.3.3.17. Australia
      • 10.3.3.18. Overview
        • 10.3.3.18.1. Australia: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn)
        • 10.3.3.18.2. Australia: Sickle Cell Disease Treatment Market Revenue and Forecast to 2030 (US$ Mn)
        • 10.3.3.18.3. Australia: Malaria Treatment Market, by Treatment
        • 10.3.3.18.4. Australia: Sickle Cell Disease Treatment Market, by Treatment
        • 10.3.3.18.5. Australia: Malaria -Malaria Treatment Market, by Route of Administration
        • 10.3.3.18.6. Australia: Sickle Cell Disease Treatment Market, by Route of Administration
        • 10.3.3.18.7. Australia: Malaria Treatment Market, by Distribution Channel
          • 10.3.3.18.7.1. Australia: Malaria Treatment Market, by Hospital Pharmacies
          • 10.3.3.18.7.2. Australia: Malaria Treatment Market, by Retail Pharmacies
        • 10.3.3.18.8. Australia: Sickle Cell Disease Treatment Market, by Distribution Channel
          • 10.3.3.18.8.1. Australia: Sickle Cell Disease Treatment Market, by Hospital Pharmacies
          • 10.3.3.18.8.2. Australia: Sickle Cell Disease Treatment Market, by Retail Pharmacies
      • 10.3.3.19. Rest of Asia Pacific
      • 10.3.3.20. Overview
        • 10.3.3.20.1. Rest of Asia Pacific: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn)
        • 10.3.3.20.2. Rest of Asia Pacific: Sickle Cell Disease Treatment Market Revenue and Forecast to 2030 (US$ Mn)
        • 10.3.3.20.3. Rest of Asia Pacific: Malaria Treatment Market, by Treatment
        • 10.3.3.20.4. Rest of Asia Pacific: Sickle Cell Disease Treatment Market, by Treatment
        • 10.3.3.20.5. Rest of Asia Pacific: Malaria -Malaria Treatment Market, by Route of Administration
        • 10.3.3.20.6. Rest of Asia Pacific: Sickle Cell Disease Treatment Market, by Route of Administration
        • 10.3.3.20.7. Rest of Asia Pacific: Malaria Treatment Market, by Distribution Channel
          • 10.3.3.20.7.1. Rest of Asia Pacific: Malaria Treatment Market, by Hospital Pharmacies
          • 10.3.3.20.7.2. Rest of Asia Pacific: Malaria Treatment Market, by Retail Pharmacies
        • 10.3.3.20.8. Rest of Asia Pacific: Sickle Cell Disease Treatment Market, by Distribution Channel
          • 10.3.3.20.8.1. Rest of Asia Pacific: Sickle Cell Disease Treatment Market, by Hospital Pharmacies
          • 10.3.3.20.8.2. Rest of Asia Pacific: Sickle Cell Disease Treatment Market, by Retail Pharmacies
  • 10.4. Middle East & Africa Malaria and Sickle Cell Disease Treatment Market, Revenue and Forecast To 2030
    • 10.4.1. Overview
    • 10.4.2. Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn)
    • 10.4.3. Sickle Cell Disease Treatment Market Revenue and Forecast to 2030 (US$ Mn)
      • 10.4.3.1. Middle East & Africa: Malaria Treatment Market, by Treatment
      • 10.4.3.2. Middle East & Africa: Sickle Cell Disease Treatment Market, by Treatment
      • 10.4.3.3. Middle East & Africa: Malaria Treatment Market, by Route of Administration
      • 10.4.3.4. Middle East & Africa: Sickle Cell Disease Treatment Market, by Route of Administration
      • 10.4.3.5. Middle East & Africa: Malaria Treatment Market, by Distribution Channel
        • 10.4.3.5.1. Middle East & Africa: Malaria Treatment Market, by Hospital Pharmacies
        • 10.4.3.5.2. Middle East & Africa: Malaria Treatment Market, by Retail Pharmacies
      • 10.4.3.6. Middle East & Africa: Sickle Cell Treatment Market, by Distribution Channel
        • 10.4.3.6.1. Middle East & Africa: Sickle Cell Treatment Market, by Hospital Pharmacies
        • 10.4.3.6.2. Middle East & Africa: Sickle Cell Treatment Market, by Retail Pharmacies
      • 10.4.3.7. Middle East & Africa: Malaria Treatment Market, by Country
      • 10.4.3.8. Middle East & Africa: Sickle Cell Disease Treatment Market, by Country
      • 10.4.3.9. Saudi Arabia
      • 10.4.3.10. Overview
        • 10.4.3.10.1. Saudi Arabia: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn)
        • 10.4.3.10.2. Saudi Arabia: Sickle Cell Disease Treatment Market Revenue and Forecast to 2030 (US$ Mn)
        • 10.4.3.10.3. Saudi Arabia: Malaria Treatment Market, by Treatment
        • 10.4.3.10.4. Saudi Arabia: Sickle Cell Disease Treatment Market, by Treatment
        • 10.4.3.10.5. Saudi Arabia: Malaria -Malaria Treatment Market, by Route of Administration
        • 10.4.3.10.6. Saudi Arabia: Sickle Cell Disease Treatment Market, by Route of Administration
        • 10.4.3.10.7. Saudi Arabia: Malaria Treatment Market, by Distribution Channel
          • 10.4.3.10.7.1. Saudi Arabia: Malaria Treatment Market, by Hospital Pharmacies
          • 10.4.3.10.7.2. Saudi Arabia: Malaria Treatment Market, by Retail Pharmacies
        • 10.4.3.10.8. Saudi Arabia: Sickle Cell Disease Treatment Market, by Distribution Channel
          • 10.4.3.10.8.1. Saudi Arabia: Sickle Cell Disease Treatment Market, by Hospital Pharmacies
          • 10.4.3.10.8.2. Saudi Arabia: Sickle Cell Disease Treatment Market, by Retail Pharmacies
      • 10.4.3.11. UAE
      • 10.4.3.12. Overview
        • 10.4.3.12.1. UAE: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn)
        • 10.4.3.12.2. UAE: Sickle Cell Disease Treatment Market Revenue and Forecast to 2030 (US$ Mn)
        • 10.4.3.12.3. UAE: Malaria Treatment Market, by Treatment
        • 10.4.3.12.4. UAE: Sickle Cell Disease Treatment Market, by Treatment
        • 10.4.3.12.5. UAE: Malaria -Malaria Treatment Market, by Route of Administration
        • 10.4.3.12.6. UAE: Sickle Cell Disease Treatment Market, by Route of Administration
        • 10.4.3.12.7. UAE: Malaria Treatment Market, by Distribution Channel
          • 10.4.3.12.7.1. UAE: Malaria Treatment Market, by Hospital Pharmacies
          • 10.4.3.12.7.2. UAE: Malaria Treatment Market, by Retail Pharmacies
        • 10.4.3.12.8. UAE: Sickle Cell Disease Treatment Market, by Distribution Channel
          • 10.4.3.12.8.1. UAE: Sickle Cell Disease Treatment Market, by Hospital Pharmacies
          • 10.4.3.12.8.2. UAE: Sickle Cell Disease Treatment Market, by Retail Pharmacies
      • 10.4.3.13. South Africa
      • 10.4.3.14. Overview
        • 10.4.3.14.1. South Africa: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn)
        • 10.4.3.14.2. South Africa: Sickle Cell Disease Treatment Market Revenue and Forecast to 2030 (US$ Mn)
        • 10.4.3.14.3. South Africa: Malaria Treatment Market, by Treatment
        • 10.4.3.14.4. South Africa: Sickle Cell Disease Treatment Market, by Treatment
        • 10.4.3.14.5. South Africa: Malaria -Malaria Treatment Market, by Route of Administration
        • 10.4.3.14.6. South Africa: Sickle Cell Disease Treatment Market, by Route of Administration
        • 10.4.3.14.7. South Africa: Malaria Treatment Market, by Distribution Channel
          • 10.4.3.14.7.1. South Africa: Malaria Treatment Market, by Hospital Pharmacies
          • 10.4.3.14.7.2. South Africa: Malaria Treatment Market, by Retail Pharmacies
        • 10.4.3.14.8. South Africa: Sickle Cell Disease Treatment Market, by Distribution Channel
          • 10.4.3.14.8.1. South Africa: Sickle Cell Disease Treatment Market, by Hospital Pharmacies
          • 10.4.3.14.8.2. South Africa: Sickle Cell Disease Treatment Market, by Retail Pharmacies
      • 10.4.3.15. Kenya
      • 10.4.3.16. Overview
        • 10.4.3.16.1. Kenya: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn)
        • 10.4.3.16.2. Kenya: Sickle Cell Disease Treatment Market Revenue and Forecast to 2030 (US$ Mn)
        • 10.4.3.16.3. Kenya: Malaria Treatment Market, by Treatment
        • 10.4.3.16.4. Kenya: Sickle Cell Disease Treatment Market, by Treatment
        • 10.4.3.16.5. Kenya: Malaria -Malaria Treatment Market, by Route of Administration
        • 10.4.3.16.6. Kenya: Sickle Cell Disease Treatment Market, by Route of Administration
        • 10.4.3.16.7. Kenya: Malaria Treatment Market, by Distribution Channel
          • 10.4.3.16.7.1. Kenya: Malaria Treatment Market, by Hospital Pharmacies
          • 10.4.3.16.7.2. Kenya: Malaria Treatment Market, by Retail Pharmacies
        • 10.4.3.16.8. Kenya: Sickle Cell Disease Treatment Market, by Distribution Channel
          • 10.4.3.16.8.1. Kenya: Sickle Cell Disease Treatment Market, by Hospital Pharmacies
          • 10.4.3.16.8.2. Kenya: Sickle Cell Disease Treatment Market, by Retail Pharmacies
      • 10.4.3.17. Tanzania
      • 10.4.3.18. Overview
        • 10.4.3.18.1. Tanzania: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn)
        • 10.4.3.18.2. Tanzania: Sickle Cell Disease Treatment Market Revenue and Forecast to 2030 (US$ Mn)
        • 10.4.3.18.3. Tanzania: Malaria Treatment Market, by Treatment
        • 10.4.3.18.4. Tanzania: Sickle Cell Disease Treatment Market, by Treatment
        • 10.4.3.18.5. Tanzania: Malaria -Malaria Treatment Market, by Route of Administration
        • 10.4.3.18.6. Tanzania: Sickle Cell Disease Treatment Market, by Route of Administration
        • 10.4.3.18.7. Tanzania: Malaria Treatment Market, by Distribution Channel
          • 10.4.3.18.7.1. Tanzania: Malaria Treatment Market, by Hospital Pharmacies
          • 10.4.3.18.7.2. Tanzania: Malaria Treatment Market, by Retail Pharmacies
        • 10.4.3.18.8. Tanzania: Sickle Cell Disease Treatment Market, by Distribution Channel
          • 10.4.3.18.8.1. Tanzania: Sickle Cell Disease Treatment Market, by Hospital Pharmacies
          • 10.4.3.18.8.2. Tanzania: Sickle Cell Disease Treatment Market, by Retail Pharmacies
      • 10.4.3.19. Rwanda
      • 10.4.3.20. Overview
        • 10.4.3.20.1. Rwanda: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn)
        • 10.4.3.20.2. Rwanda: Sickle Cell Disease Treatment Market Revenue and Forecast to 2030 (US$ Mn)
        • 10.4.3.20.3. Rwanda: Malaria Treatment Market, by Treatment
        • 10.4.3.20.4. Rwanda: Sickle Cell Disease Treatment Market, by Treatment
        • 10.4.3.20.5. Rwanda: Malaria -Malaria Treatment Market, by Route of Administration
        • 10.4.3.20.6. Rwanda: Sickle Cell Disease Treatment Market, by Route of Administration
        • 10.4.3.20.7. Rwanda: Malaria Treatment Market, by Distribution Channel
          • 10.4.3.20.7.1. Rwanda: Malaria Treatment Market, by Hospital Pharmacies
          • 10.4.3.20.7.2. Rwanda: Malaria Treatment Market, by Retail Pharmacies
        • 10.4.3.20.8. Rwanda: Sickle Cell Disease Treatment Market, by Distribution Channel
          • 10.4.3.20.8.1. Rwanda: Sickle Cell Disease Treatment Market, by Hospital Pharmacies
          • 10.4.3.20.8.2. Rwanda: Sickle Cell Disease Treatment Market, by Retail Pharmacies
      • 10.4.3.21. Nigeria
      • 10.4.3.22. Overview
        • 10.4.3.22.1. Nigeria: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn)
        • 10.4.3.22.2. Nigeria: Sickle Cell Disease Treatment Market Revenue and Forecast to 2030 (US$ Mn)
        • 10.4.3.22.3. Nigeria: Malaria Treatment Market, by Treatment
        • 10.4.3.22.4. Nigeria: Sickle Cell Disease Treatment Market, by Treatment
        • 10.4.3.22.5. Nigeria: Malaria -Malaria Treatment Market, by Route of Administration
        • 10.4.3.22.6. Nigeria: Sickle Cell Disease Treatment Market, by Route of Administration
        • 10.4.3.22.7. Nigeria: Malaria Treatment Market, by Distribution Channel
          • 10.4.3.22.7.1. Nigeria: Malaria Treatment Market, by Hospital Pharmacies
          • 10.4.3.22.7.2. Nigeria: Malaria Treatment Market, by Retail Pharmacies
        • 10.4.3.22.8. Nigeria: Sickle Cell Disease Treatment Market, by Distribution Channel
          • 10.4.3.22.8.1. Nigeria: Sickle Cell Disease Treatment Market, by Hospital Pharmacies
          • 10.4.3.22.8.2. Nigeria: Sickle Cell Disease Treatment Market, by Retail Pharmacies
      • 10.4.3.23. Ghana
      • 10.4.3.24. Overview
        • 10.4.3.24.1. Ghana: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn)
        • 10.4.3.24.2. Ghana: Sickle Cell Disease Treatment Market Revenue and Forecast to 2030 (US$ Mn)
        • 10.4.3.24.3. Ghana: Malaria Treatment Market, by Treatment
        • 10.4.3.24.4. Ghana: Sickle Cell Disease Treatment Market, by Treatment
        • 10.4.3.24.5. Ghana: Malaria -Malaria Treatment Market, by Route of Administration
        • 10.4.3.24.6. Ghana: Sickle Cell Disease Treatment Market, by Route of Administration
        • 10.4.3.24.7. Ghana: Malaria Treatment Market, by Distribution Channel
          • 10.4.3.24.7.1. Ghana: Malaria Treatment Market, by Hospital Pharmacies
          • 10.4.3.24.7.2. Ghana: Malaria Treatment Market, by Retail Pharmacies
        • 10.4.3.24.8. Ghana: Sickle Cell Disease Treatment Market, by Distribution Channel
          • 10.4.3.24.8.1. Ghana: Sickle Cell Disease Treatment Market, by Hospital Pharmacies
          • 10.4.3.24.8.2. Ghana: Sickle Cell Disease Treatment Market, by Retail Pharmacies
      • 10.4.3.25. Uganda
      • 10.4.3.26. Overview
        • 10.4.3.26.1. Uganda: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn)
        • 10.4.3.26.2. Uganda: Sickle Cell Disease Treatment Market Revenue and Forecast to 2030 (US$ Mn)
        • 10.4.3.26.3. Uganda: Malaria Treatment Market, by Treatment
        • 10.4.3.26.4. Uganda: Sickle Cell Disease Treatment Market, by Treatment
        • 10.4.3.26.5. Uganda: Malaria -Malaria Treatment Market, by Route of Administration
        • 10.4.3.26.6. Uganda: Sickle Cell Disease Treatment Market, by Route of Administration
        • 10.4.3.26.7. Uganda: Malaria Treatment Market, by Distribution Channel
          • 10.4.3.26.7.1. Uganda: Malaria Treatment Market, by Hospital Pharmacies
          • 10.4.3.26.7.2. Uganda: Malaria Treatment Market, by Retail Pharmacies
        • 10.4.3.26.8. Uganda: Sickle Cell Disease Treatment Market, by Distribution Channel
          • 10.4.3.26.8.1. Uganda: Sickle Cell Disease Treatment Market, by Hospital Pharmacies
          • 10.4.3.26.8.2. Uganda: Sickle Cell Disease Treatment Market, by Retail Pharmacies
      • 10.4.3.27. Angola
      • 10.4.3.28. Overview
        • 10.4.3.28.1. Angola: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn)
        • 10.4.3.28.2. Angola: Sickle Cell Disease Treatment Market Revenue and Forecast to 2030 (US$ Mn)
        • 10.4.3.28.3. Angola: Malaria Treatment Market, by Treatment
        • 10.4.3.28.4. Angola: Sickle Cell Disease Treatment Market, by Treatment
        • 10.4.3.28.5. Angola: Malaria -Malaria Treatment Market, by Route of Administration
        • 10.4.3.28.6. Angola: Sickle Cell Disease Treatment Market, by Route of Administration
        • 10.4.3.28.7. Angola: Malaria Treatment Market, by Distribution Channel
          • 10.4.3.28.7.1. Angola: Malaria Treatment Market, by Hospital Pharmacies
          • 10.4.3.28.7.2. Angola: Malaria Treatment Market, by Retail Pharmacies
        • 10.4.3.28.8. Angola: Sickle Cell Disease Treatment Market, by Distribution Channel
          • 10.4.3.28.8.1. Angola: Sickle Cell Disease Treatment Market, by Hospital Pharmacies
          • 10.4.3.28.8.2. Angola: Sickle Cell Disease Treatment Market, by Retail Pharmacies
      • 10.4.3.29. Cameroon
      • 10.4.3.30. Overview
        • 10.4.3.30.1. Cameroon: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn)
        • 10.4.3.30.2. Cameroon: Sickle Cell Disease Treatment Market Revenue and Forecast to 2030 (US$ Mn)
        • 10.4.3.30.3. Cameroon: Malaria Treatment Market, by Treatment
        • 10.4.3.30.4. Cameroon: Sickle Cell Disease Treatment Market, by Treatment
        • 10.4.3.30.5. Cameroon: Malaria -Malaria Treatment Market, by Route of Administration
        • 10.4.3.30.6. Cameroon: Sickle Cell Disease Treatment Market, by Route of Administration
        • 10.4.3.30.7. Cameroon: Malaria Treatment Market, by Distribution Channel
          • 10.4.3.30.7.1. Cameroon: Malaria Treatment Market, by Hospital Pharmacies
          • 10.4.3.30.7.2. Cameroon: Malaria Treatment Market, by Retail Pharmacies
        • 10.4.3.30.8. Cameroon: Sickle Cell Disease Treatment Market, by Distribution Channel
          • 10.4.3.30.8.1. Cameroon: Sickle Cell Disease Treatment Market, by Hospital Pharmacies
          • 10.4.3.30.8.2. Cameroon: Sickle Cell Disease Treatment Market, by Retail Pharmacies
      • 10.4.3.31. Senegal
      • 10.4.3.32. Overview
        • 10.4.3.32.1. Senegal: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn)
        • 10.4.3.32.2. Senegal: Sickle Cell Disease Treatment Market Revenue and Forecast to 2030 (US$ Mn)
        • 10.4.3.32.3. Senegal: Malaria Treatment Market, by Treatment
        • 10.4.3.32.4. Senegal: Sickle Cell Disease Treatment Market, by Treatment
        • 10.4.3.32.5. Senegal: Malaria -Malaria Treatment Market, by Route of Administration
        • 10.4.3.32.6. Senegal: Sickle Cell Disease Treatment Market, by Route of Administration
        • 10.4.3.32.7. Senegal: Malaria Treatment Market, by Distribution Channel
          • 10.4.3.32.7.1. Senegal: Malaria Treatment Market, by Hospital Pharmacies
          • 10.4.3.32.7.2. Senegal: Malaria Treatment Market, by Retail Pharmacies
        • 10.4.3.32.8. Senegal: Sickle Cell Disease Treatment Market, by Distribution Channel
          • 10.4.3.32.8.1. Senegal: Sickle Cell Disease Treatment Market, by Hospital Pharmacies
          • 10.4.3.32.8.2. Senegal: Sickle Cell Disease Treatment Market, by Retail Pharmacies
      • 10.4.3.33. Zambia
      • 10.4.3.34. Overview
        • 10.4.3.34.1. Zambia: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn)
        • 10.4.3.34.2. Zambia: Sickle Cell Disease Treatment Market Revenue and Forecast to 2030 (US$ Mn)
        • 10.4.3.34.3. Zambia: Malaria Treatment Market, by Treatment
        • 10.4.3.34.4. Zambia: Sickle Cell Disease Treatment Market, by Treatment
        • 10.4.3.34.5. Zambia: Malaria -Malaria Treatment Market, by Route of Administration
        • 10.4.3.34.6. Zambia: Sickle Cell Disease Treatment Market, by Route of Administration
        • 10.4.3.34.7. Zambia: Malaria Treatment Market, by Distribution Channel
          • 10.4.3.34.7.1. Zambia: Malaria Treatment Market, by Hospital Pharmacies
          • 10.4.3.34.7.2. Zambia: Malaria Treatment Market, by Retail Pharmacies
        • 10.4.3.34.8. Zambia: Sickle Cell Disease Treatment Market, by Distribution Channel
          • 10.4.3.34.8.1. Zambia: Sickle Cell Disease Treatment Market, by Hospital Pharmacies
          • 10.4.3.34.8.2. Zambia: Sickle Cell Disease Treatment Market, by Retail Pharmacies
      • 10.4.3.35. Rest of Middle East & Africa
      • 10.4.3.36. Overview
        • 10.4.3.36.1. Rest of Middle East & Africa: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn)
        • 10.4.3.36.2. Rest of Middle East & Africa: Sickle Cell Disease Treatment Market Revenue and Forecast to 2030 (US$ Mn)
        • 10.4.3.36.3. Rest of Middle East & Africa: Malaria Treatment Market, by Treatment
        • 10.4.3.36.4. Rest of Middle East & Africa: Sickle Cell Disease Treatment Market, by Treatment
        • 10.4.3.36.5. Rest of Middle East & Africa: Malaria -Malaria Treatment Market, by Route of Administration
        • 10.4.3.36.6. Rest of Middle East & Africa: Sickle Cell Disease Treatment Market, by Route of Administration
        • 10.4.3.36.7. Rest of Middle East & Africa: Malaria Treatment Market, by Distribution Channel
          • 10.4.3.36.7.1. Rest of Middle East & Africa: Malaria Treatment Market, by Hospital Pharmacies
          • 10.4.3.36.7.2. Rest of Middle East & Africa: Malaria Treatment Market, by Retail Pharmacies
        • 10.4.3.36.8. Rest of Middle East & Africa: Sickle Cell Disease Treatment Market, by Distribution Channel
          • 10.4.3.36.8.1. Rest of Middle East & Africa: Sickle Cell Disease Treatment Market, by Hospital Pharmacies
          • 10.4.3.36.8.2. Rest of Middle East & Africa: Sickle Cell Disease Treatment Market, by Retail Pharmacies
  • 10.5. Asia Pacific Malaria and Sickle Cell Disease Treatment Market, Revenue and Forecast To 2030
    • 10.5.1. Overview
    • 10.5.2. Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn)
    • 10.5.3. Sickle Cell Disease Treatment Market Revenue and Forecast to 2030 (US$ Mn)
      • 10.5.3.1. Asia Pacific: Malaria Treatment Market, by Treatment
      • 10.5.3.2. Asia Pacific: Sickle Cell Disease Treatment Market, by Treatment
      • 10.5.3.3. Asia Pacific: Malaria Treatment Market, by Route of Administration
      • 10.5.3.4. Asia Pacific: Sickle Cell Disease Treatment Market, by Route of Administration
      • 10.5.3.5. Asia Pacific: Malaria Treatment Market, by Distribution Channel
        • 10.5.3.5.1. Asia Pacific: Malaria Treatment Market, by Hospital Pharmacies
        • 10.5.3.5.2. Asia Pacific: Malaria Treatment Market, by Retail Pharmacies
      • 10.5.3.6. Asia Pacific: Sickle Cell Treatment Market, by Distribution Channel
        • 10.5.3.6.1. Asia Pacific: Sickle Cell Treatment Market, by Hospital Pharmacies
        • 10.5.3.6.2. Asia Pacific: Sickle Cell Treatment Market, by Retail Pharmacies
      • 10.5.3.7. Asia Pacific: Malaria Treatment Market, by Countries
      • 10.5.3.8. Asia Pacific: Sickle Cell Disease Treatment Market, by Country
      • 10.5.3.9. China
      • 10.5.3.10. Overview
        • 10.5.3.10.1. China: Sickle Cell Disease Treatment Market Revenue and Forecast to 2030 (US$ Mn)
        • 10.5.3.10.2. China: Sickle Cell Disease Treatment Market, by Treatment
        • 10.5.3.10.3. China: Sickle Cell Disease Treatment Market, by Route of Administration
        • 10.5.3.10.4. China: Sickle Cell Disease Treatment Market, by Distribution Channel
          • 10.5.3.10.4.1. China: Sickle Cell Disease Treatment Market, by Hospital Pharmacies
          • 10.5.3.10.4.2. China: Sickle Cell Disease Treatment Market, by Retail Pharmacies
      • 10.5.3.11. Japan
      • 10.5.3.12. Overview
        • 10.5.3.12.1. Japan: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn)
        • 10.5.3.12.2. Japan: Sickle Cell Disease Treatment Market Revenue and Forecast to 2030 (US$ Mn)
        • 10.5.3.12.3. Japan: Malaria Treatment Market, by Treatment
        • 10.5.3.12.4. Japan: Sickle Cell Disease Treatment Market, by Treatment
        • 10.5.3.12.5. Japan: Malaria -Malaria Treatment Market, by Route of Administration
        • 10.5.3.12.6. Japan: Sickle Cell Disease Treatment Market, by Route of Administration
        • 10.5.3.12.7. Japan: Malaria Treatment Market, by Distribution Channel
          • 10.5.3.12.7.1. Japan: Malaria Treatment Market, by Hospital Pharmacies
          • 10.5.3.12.7.2. Japan: Malaria Treatment Market, by Retail Pharmacies
        • 10.5.3.12.8. Japan: Sickle Cell Disease Treatment Market, by Distribution Channel
          • 10.5.3.12.8.1. Japan: Sickle Cell Disease Treatment Market, by Hospital Pharmacies
          • 10.5.3.12.8.2. Japan: Sickle Cell Disease Treatment Market, by Retail Pharmacies
      • 10.5.3.13. India
      • 10.5.3.14. Overview
        • 10.5.3.14.1. India: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn)
        • 10.5.3.14.2. India: Sickle Cell Disease Treatment Market Revenue and Forecast to 2030 (US$ Mn)
        • 10.5.3.14.3. India: Malaria Treatment Market, by Treatment
        • 10.5.3.14.4. India: Sickle Cell Disease Treatment Market, by Treatment
        • 10.5.3.14.5. India: Malaria -Malaria Treatment Market, by Route of Administration
        • 10.5.3.14.6. India: Sickle Cell Disease Treatment Market, by Route of Administration
        • 10.5.3.14.7. India: Malaria Treatment Market, by Distribution Channel
          • 10.5.3.14.7.1. India: Malaria Treatment Market, by Hospital Pharmacies
          • 10.5.3.14.7.2. India: Malaria Treatment Market, by Retail Pharmacies
        • 10.5.3.14.8. India: Sickle Cell Disease Treatment Market, by Distribution Channel
          • 10.5.3.14.8.1. India: Sickle Cell Disease Treatment Market, by Hospital Pharmacies
          • 10.5.3.14.8.2. India: Sickle Cell Disease Treatment Market, by Retail Pharmacies
      • 10.5.3.15. South Korea
      • 10.5.3.16. Overview
        • 10.5.3.16.1. South Korea: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn)
        • 10.5.3.16.2. South Korea: Sickle Cell Disease Treatment Market Revenue and Forecast to 2030 (US$ Mn)
        • 10.5.3.16.3. South Korea: Malaria Treatment Market, by Treatment
        • 10.5.3.16.4. South Korea: Sickle Cell Disease Treatment Market, by Treatment
        • 10.5.3.16.5. South Korea: Malaria -Malaria Treatment Market, by Route of Administration
        • 10.5.3.16.6. South Korea: Sickle Cell Disease Treatment Market, by Route of Administration
        • 10.5.3.16.7. South Korea: Malaria Treatment Market, by Distribution Channel
          • 10.5.3.16.7.1. South Korea: Malaria Treatment Market, by Hospital Pharmacies
          • 10.5.3.16.7.2. South Korea: Malaria Treatment Market, by Retail Pharmacies
        • 10.5.3.16.8. South Korea: Sickle Cell Disease Treatment Market, by Distribution Channel
          • 10.5.3.16.8.1. South Korea: Sickle Cell Disease Treatment Market, by Hospital Pharmacies
          • 10.5.3.16.8.2. South Korea: Sickle Cell Disease Treatment Market, by Retail Pharmacies
      • 10.5.3.17. Australia
      • 10.5.3.18. Overview
        • 10.5.3.18.1. Australia: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn)
        • 10.5.3.18.2. Australia: Sickle Cell Disease Treatment Market Revenue and Forecast to 2030 (US$ Mn)
        • 10.5.3.18.3. Australia: Malaria Treatment Market, by Treatment
        • 10.5.3.18.4. Australia: Sickle Cell Disease Treatment Market, by Treatment
        • 10.5.3.18.5. Australia: Malaria -Malaria Treatment Market, by Route of Administration
        • 10.5.3.18.6. Australia: Sickle Cell Disease Treatment Market, by Route of Administration
        • 10.5.3.18.7. Australia: Malaria Treatment Market, by Distribution Channel
          • 10.5.3.18.7.1. Australia: Malaria Treatment Market, by Hospital Pharmacies
          • 10.5.3.18.7.2. Australia: Malaria Treatment Market, by Retail Pharmacies
        • 10.5.3.18.8. Australia: Sickle Cell Disease Treatment Market, by Distribution Channel
          • 10.5.3.18.8.1. Australia: Sickle Cell Disease Treatment Market, by Hospital Pharmacies
          • 10.5.3.18.8.2. Australia: Sickle Cell Disease Treatment Market, by Retail Pharmacies
      • 10.5.3.19. Rest of Asia Pacific
      • 10.5.3.20. Overview
        • 10.5.3.20.1. Rest of Asia Pacific: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn)
        • 10.5.3.20.2. Rest of Asia Pacific: Sickle Cell Disease Treatment Market Revenue and Forecast to 2030 (US$ Mn)
        • 10.5.3.20.3. Rest of Asia Pacific: Malaria Treatment Market, by Treatment
        • 10.5.3.20.4. Rest of Asia Pacific: Sickle Cell Disease Treatment Market, by Treatment
        • 10.5.3.20.5. Rest of Asia Pacific: Malaria -Malaria Treatment Market, by Route of Administration
        • 10.5.3.20.6. Rest of Asia Pacific: Sickle Cell Disease Treatment Market, by Route of Administration
        • 10.5.3.20.7. Rest of Asia Pacific: Malaria Treatment Market, by Distribution Channel
          • 10.5.3.20.7.1. Rest of Asia Pacific: Malaria Treatment Market, by Hospital Pharmacies
          • 10.5.3.20.7.2. Rest of Asia Pacific: Malaria Treatment Market, by Retail Pharmacies
        • 10.5.3.20.8. Rest of Asia Pacific: Sickle Cell Disease Treatment Market, by Distribution Channel
          • 10.5.3.20.8.1. Rest of Asia Pacific: Sickle Cell Disease Treatment Market, by Hospital Pharmacies
          • 10.5.3.20.8.2. Rest of Asia Pacific: Sickle Cell Disease Treatment Market, by Retail Pharmacies
  • 10.6. South & Central America Malaria and Sickle Cell Disease Treatment Market, Revenue and Forecast To 2030
    • 10.6.1. Overview
    • 10.6.2. Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn)
    • 10.6.3. Sickle Cell Disease Treatment Market Revenue and Forecast to 2030 (US$ Mn)
      • 10.6.3.1. South & Central America: Malaria Treatment Market, by Treatment
      • 10.6.3.2. South & Central America: Sickle Cell Disease Treatment Market, by Treatment
      • 10.6.3.3. South & Central America: Malaria Treatment Market, by Route of Administration
      • 10.6.3.4. South & Central America: Sickle Cell Disease Treatment Market, by Route of Administration
      • 10.6.3.5. South & Central America: Malaria Treatment Market, by Distribution Channel
        • 10.6.3.5.1. South & Central America: Malaria Treatment Market, by Hospital Pharmacies
        • 10.6.3.5.2. South & Central America: Malaria Treatment Market, by Retail Pharmacies
      • 10.6.3.6. South & Central America: Sickle Cell Treatment Market, by Distribution Channel
        • 10.6.3.6.1. South & Central America: Sickle Cell Treatment Market, by Hospital Pharmacies
        • 10.6.3.6.2. South & Central America: Sickle Cell Treatment Market, by Retail Pharmacies
      • 10.6.3.7. South & Central America: Malaria Treatment Market, by Countries
      • 10.6.3.8. South & Central America: Sickle Cell Disease Treatment Market, by Countries
      • 10.6.3.9. Brazil
      • 10.6.3.10. Overview
        • 10.6.3.10.1. Brazil: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn)
        • 10.6.3.10.2. Brazil: Sickle Cell Disease Treatment Market Revenue and Forecast to 2030 (US$ Mn)
        • 10.6.3.10.3. Brazil: Malaria Treatment Market, by Treatment
        • 10.6.3.10.4. Brazil: Sickle Cell Disease Treatment Market, by Treatment
        • 10.6.3.10.5. Brazil: Malaria -Malaria Treatment Market, by Route of Administration
        • 10.6.3.10.6. Brazil: Sickle Cell Disease Treatment Market, by Route of Administration
        • 10.6.3.10.7. Brazil: Malaria Treatment Market, by Distribution Channel
          • 10.6.3.10.7.1. Brazil: Malaria Treatment Market, by Hospital Pharmacies
          • 10.6.3.10.7.2. Brazil: Malaria Treatment Market, by Retail Pharmacies
        • 10.6.3.10.8. Brazil: Sickle Cell Disease Treatment Market, by Distribution Channel
          • 10.6.3.10.8.1. Brazil: Sickle Cell Disease Treatment Market, by Hospital Pharmacies
          • 10.6.3.10.8.2. Brazil: Sickle Cell Disease Treatment Market, by Retail Pharmacies
      • 10.6.3.11. Argentina
      • 10.6.3.12. Overview
        • 10.6.3.12.1. Argentina: Sickle Cell Disease Treatment Market Revenue and Forecast to 2030 (US$ Mn)
        • 10.6.3.12.2. Argentina: Sickle Cell Disease Treatment Market, by Treatment
        • 10.6.3.12.3. Argentina: Sickle Cell Disease Treatment Market, by Route of Administration
        • 10.6.3.12.4. Argentina: Sickle Cell Disease Treatment Market, by Distribution Channel
          • 10.6.3.12.4.1. Argentina: Sickle Cell Disease Treatment Market, by Hospital Pharmacies
          • 10.6.3.12.4.2. Argentina: Sickle Cell Disease Treatment Market, by Retail Pharmacies
      • 10.6.3.13. Rest of South & Central America
      • 10.6.3.14. Overview
        • 10.6.3.14.1. Rest of South & Central America: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn)
        • 10.6.3.14.2. Rest of South & Central America: Sickle Cell Disease Treatment Market Revenue and Forecast to 2030 (US$ Mn)
        • 10.6.3.14.3. Rest of South & Central America: Malaria Treatment Market, by Treatment
        • 10.6.3.14.4. Rest of South & Central America: Sickle Cell Disease Treatment Market, by Treatment
        • 10.6.3.14.5. Rest of South & Central America: Malaria -Malaria Treatment Market, by Route of Administration
        • 10.6.3.14.6. Rest of South & Central America: Sickle Cell Disease Treatment Market, by Route of Administration
        • 10.6.3.14.7. Rest of South & Central America: Malaria Treatment Market, by Distribution Channel
          • 10.6.3.14.7.1. Rest of South & Central America: Malaria Treatment Market, by Hospital Pharmacies
          • 10.6.3.14.7.2. Rest of South & Central America: Malaria Treatment Market, by Retail Pharmacies
        • 10.6.3.14.8. Rest of South & Central America: Sickle Cell Disease Treatment Market, by Distribution Channel
          • 10.6.3.14.8.1. Rest of South & Central America: Sickle Cell Disease Treatment Market, by Hospital Pharmacies
          • 10.6.3.14.8.2. Rest of South & Central America: Sickle Cell Disease Treatment Market, by Retail Pharmacies

11. Malaria and Sickle Cell Disease Treatment Market Industry Landscape

  • 11.1. Overview
  • 11.2. Growth Strategies in the Malaria and Sickle Cell Disease Treatment Market
  • 11.3. Inorganic Growth Strategies
    • 11.3.1. Overview
  • 11.4. Organic Growth Strategies
    • 11.4.1. Overview

12. Company Profiles

  • 12.1.1. Cipla Ltd
  • 12.1.1. Key Facts
  • 12.1.2. Business Description
  • 12.1.3. Products and Services
  • 12.1.4. Financial Overview
  • 12.1.5. SWOT Analysis
  • 12.1.6. Key Developments
  • 12.2. Sun Pharmaceutical Industries Ltd
    • 12.2.1. Key Facts
    • 12.2.2. Business Description
    • 12.2.3. Products and Services
    • 12.2.4. Financial Overview
    • 12.2.5. SWOT Analysis
    • 12.2.6. Key Developments
  • 12.3. Sanofi SA
    • 12.3.1. Key Facts
    • 12.3.2. Business Description
    • 12.3.3. Products and Services
    • 12.3.4. Financial Overview
    • 12.3.5. SWOT Analysis
    • 12.3.6. Key Developments
  • 12.4. GSK Plc
    • 12.4.1. Key Facts
    • 12.4.2. Business Description
    • 12.4.3. Products and Services
    • 12.4.4. Financial Overview
    • 12.4.5. SWOT Analysis
    • 12.4.6. Key Developments
  • 12.5. Novartis AG
    • 12.5.1. Key Facts
    • 12.5.2. Business Description
    • 12.5.3. Products and Services
    • 12.5.4. Financial Overview
    • 12.5.5. SWOT Analysis
    • 12.5.6. Key Developments
  • 12.6. Pfizer Inc
    • 12.6.1. Key Facts
    • 12.6.2. Business Description
    • 12.6.3. Products and Service
    • 12.6.4. Financial Overview
    • 12.6.5. SWOT Analysis
    • 12.6.6. Key Developments
  • 12.7. Emmaus Life Sciences Inc
    • 12.7.1. Key Facts
    • 12.7.2. Business Description
    • 12.7.3. Products and Services
    • 12.7.4. Financial Overview
    • 12.7.5. SWOT Analysis
    • 12.7.6. Key Developments
  • 12.8. AdvaCare Pharma USA LLC
    • 12.8.1. Key Facts
    • 12.8.2. Business Description
    • 12.8.3. Products and Services
    • 12.8.4. Financial Overview
    • 12.8.5. SWOT Analysis
    • 12.8.6. Key Developments
  • 12.9. VLP Therapeutics LLC
    • 12.9.1. Key Facts
    • 12.9.2. Business Description
    • 12.9.3. Products and Services
    • 12.9.4. Financial Overview
    • 12.9.5. SWOT Analysis
    • 12.9.6. Key Developments
  • 12.10. Lupin Ltd
    • 12.10.1. Key Facts
    • 12.10.2. Business Description
    • 12.10.3. Products and Services
    • 12.10.4. Financial Overview
    • 12.10.5. SWOT Analysis
    • 12.10.6. Key Developments
  • 12.11. Teva Pharmaceutical Industries Ltd
    • 12.11.1. Key Facts
    • 12.11.2. Business Description
    • 12.11.3. Products and Services
    • 12.11.4. Financial Overview
    • 12.11.5. SWOT Analysis
    • 12.11.6. Key Developments

13. Appendix

  • 13.1. About Us
  • 13.2. Glossary of Terms

14. Appendix